WO1999005574A1 - Method and system for providing a probe array chip design database - Google Patents

Method and system for providing a probe array chip design database Download PDF

Info

Publication number
WO1999005574A1
WO1999005574A1 PCT/US1998/015456 US9815456W WO9905574A1 WO 1999005574 A1 WO1999005574 A1 WO 1999005574A1 US 9815456 W US9815456 W US 9815456W WO 9905574 A1 WO9905574 A1 WO 9905574A1
Authority
WO
WIPO (PCT)
Prior art keywords
records
probe
item
sequence
genomic
Prior art date
Application number
PCT/US1998/015456
Other languages
French (fr)
Inventor
David J. Balaban
Earl A. Hubbell
Michael Mittman
Gloria Cheung
Josie Dai
Original Assignee
Affymetrix, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Affymetrix, Inc. filed Critical Affymetrix, Inc.
Priority to JP2000504489A priority Critical patent/JP2001511550A/en
Priority to EP98937126A priority patent/EP0998697A4/en
Publication of WO1999005574A1 publication Critical patent/WO1999005574A1/en

Links

Classifications

    • HELECTRICITY
    • H04ELECTRIC COMMUNICATION TECHNIQUE
    • H04MTELEPHONIC COMMUNICATION
    • H04M1/00Substation equipment, e.g. for use by subscribers
    • H04M1/006Call diverting means
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809Methods for determination or identification of nucleic acids involving differential detection
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/30Microarray design
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00ICT programming tools or database systems specially adapted for bioinformatics
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • HELECTRICITY
    • H04ELECTRIC COMMUNICATION TECHNIQUE
    • H04MTELEPHONIC COMMUNICATION
    • H04M1/00Substation equipment, e.g. for use by subscribers
    • H04M1/72Mobile telephones; Cordless telephones, i.e. devices for establishing wireless links to base stations without route selection
    • H04M1/724User interfaces specially adapted for cordless or mobile telephones
    • HELECTRICITY
    • H04ELECTRIC COMMUNICATION TECHNIQUE
    • H04MTELEPHONIC COMMUNICATION
    • H04M2207/00Type of exchange or network, i.e. telephonic medium, in which the telephonic communication takes place
    • H04M2207/20Type of exchange or network, i.e. telephonic medium, in which the telephonic communication takes place hybrid systems
    • H04M2207/206Type of exchange or network, i.e. telephonic medium, in which the telephonic communication takes place hybrid systems composed of PSTN and wireless network
    • HELECTRICITY
    • H04ELECTRIC COMMUNICATION TECHNIQUE
    • H04MTELEPHONIC COMMUNICATION
    • H04M3/00Automatic or semi-automatic exchanges
    • H04M3/42Systems providing special services or facilities to subscribers
    • H04M3/46Arrangements for calling a number of substations in a predetermined sequence until an answer is obtained
    • HELECTRICITY
    • H04ELECTRIC COMMUNICATION TECHNIQUE
    • H04MTELEPHONIC COMMUNICATION
    • H04M3/00Automatic or semi-automatic exchanges
    • H04M3/42Systems providing special services or facilities to subscribers
    • H04M3/54Arrangements for diverting calls for one subscriber to another predetermined subscriber
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S128/00Surgery
    • Y10S128/92Computer assisted medical diagnostics
    • Y10S128/922Computer assisted medical diagnostics including image analysis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S707/00Data processing: database and file management or data structures
    • Y10S707/912Applications of a database
    • Y10S707/923Intellectual property
    • Y10S707/924Patent procedure
    • Y10S707/925Drafting an application
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S707/00Data processing: database and file management or data structures
    • Y10S707/953Organization of data
    • Y10S707/955Object-oriented
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S707/00Data processing: database and file management or data structures
    • Y10S707/99931Database or file accessing
    • Y10S707/99933Query processing, i.e. searching
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S707/00Data processing: database and file management or data structures
    • Y10S707/99931Database or file accessing
    • Y10S707/99933Query processing, i.e. searching
    • Y10S707/99934Query formulation, input preparation, or translation
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S707/00Data processing: database and file management or data structures
    • Y10S707/99941Database schema or data structure
    • Y10S707/99944Object-oriented database structure
    • Y10S707/99945Object-oriented database structure processing

Definitions

  • the present invention relates to the collection and storage of information pertaining to chips for processing samples.
  • a fluorescently labeled nucleic acid is then brought into contact with the chip and a scanner generates an image file indicating the locations where the labeled nucleic acids bound to the chip. Based upon the identities of the probes at these locations, it becomes possible to extract information such as the monomer sequence of DNA or RNA.
  • Such systems have been used to form, for example, arrays of DNA that may be used to study and detect mutations relevant to cystic fibrosis, the P53 gene (relevant to certain cancers), HIV, and other genetic characteristics.
  • the probe array chips are designed to answer questions about genomic items, herein defined to include genes, expressed sequence tags (ESTs), gene clusters, and EST clusters.
  • genomic items herein defined to include genes, expressed sequence tags (ESTs), gene clusters, and EST clusters.
  • ESTs expressed sequence tags
  • Associated with information about genomic items is genetic sequence information concerning the base sequences of genomic items.
  • Probes are designed and selected for inclusion on a chip based on: 1) the identity of the genomic items to be investigated by the chip, 2) the sequence information associated with those genomic information, and 3) the type of information sought, e.g., expression analysis, polymorphism analysis, etc.
  • the interrelationships, however, among probes, genomic items, and sequence information are, however, extremely complex, greatly complicating the tasks of designing chips, effectively exploiting chips that have already been designed, and efficiently interpreting the information generated by application of the chips.
  • the present invention provides systems and method for organizing information relating to the design of polymer probe array chips including oligonucleotide array chips.
  • a database model is provided which organizes information interrelating probes on a chip, genomic items investigated by the chip, and sequence information relating to the design of the chip.
  • the model is readily translatable into database languages such as SQL.
  • the database model scales to permit storage of information about large numbers of chips having complex designs.
  • a computer-readable storage medium is provided.
  • a relational database is stored on this medium.
  • the relational database includes: a probe table including a plurality of probe records, each of the probe records specifying a polymer probe for use in one or more polymer probe arrays, a sequence item table including a plurality of sequence item records, each of the sequence item records specifying a nucleotide sequence to be investigated in the one or more polymer probe arrays, wherein there is a many-to-many relationship between the probe records and the sequence item records.
  • Fig. 1 illustrates an overall system and process for forming and analyzing arrays of biological materials such as DNA or RNA.
  • Fig. 2 A illustrates a computer system suitable for use in conjunction with the overall system of Fig. 1.
  • Fig. 2B illustrates a computer network suitable for use in conjunction with the overall system of Fig. 1.
  • Fig. 3 illustrates a key for interpreting a database model.
  • Fig. 4 illustrates a database model for maintaining information for the system and process of Fig. 1 according to one embodiment of the present invention.
  • One embodiment of the present invention operates in the context of a system for analyzing biological or other materials using arrays that themselves include probes that may be made of biological materials such as RNA or DNA.
  • the VLSIPSTM and GeneChipTM technologies provide methods of making and using very large arrays of polymers, such as nucleic acids, on chips. See U.S. Patent No. 5,143,854 and PCT Patent Publication Nos. WO 90/15070 and 92/10092, each of which is hereby incorporated by reference for all purposes.
  • Nucleic acid probes on the chip are used to detect complementary nucleic acid sequences in a sample nucleic acid of interest (the "target" nucleic acid).
  • probes need not be nucleic acid probes but may also be other polymers such as peptides.
  • Peptide probes may be used to detect the concentration of peptides, polypeptides, or polymers in a sample. The probes must be carefully selected to have bonding affinity to the compound whose concentration they are to be used to measure.
  • Fig. 1 illustrates an overall system 100 for forming and analyzing arrays of biological materials such as RNA or DNA.
  • a part of system 100 is a chip design database 102.
  • Chip design database 102 includes information about chip designs and the purposes of chips.
  • Chip design database 102 facilitates large scale design, construction, and processing of chips.
  • a chip design system 104 is used to design arrays of polymers such as biological polymers such as RNA or DNA.
  • Chip design system 104 may be, for example, an appropriately programmed Sun Workstation or personal computer or workstation, such as an IBM PC equivalent, including appropriate memory and a CPU.
  • Chip design system 104 obtains inputs from a user regarding chip design objectives including characteristics of genes of interest, and other inputs regarding the desired features of the array. All of this information may be stored in chip design database 102.
  • chip design system 104 may obtain information regarding a specific genetic sequence of interest from chip design database 102 or from external databases such as GenBank.
  • the output of chip design system 104 is a set of chip design computer files in the form of, for example, a switch matrix, as described in PCT application WO 92/10092, and other associated computer files.
  • the chip design computer files form a part of chip design database 102.
  • the chip design files are input to a mask design system (not shown) that designs the lithographic masks used in the fabrication of arrays of molecules such as DNA.
  • the mask design system designs the lithographic masks used in the fabrication of probe arrays.
  • the mask design system generates mask design files that are then used by a mask construction system (not shown) to construct masks or other synthesis patterns such as chrome-on-glass masks for use in the fabrication of polymer arrays.
  • the masks are used in a synthesis system (not shown).
  • the synthesis system includes the necessary hardware and software used to fabricate arrays of polymers on a substrate or chip.
  • the synthesis system includes a light source and a chemical flow cell on which the substrate or chip is placed. A mask is placed between the light source and the substrate/chip, and the two are translated relative to each other at appropriate times for deprotection of selected regions of the chip. Selected chemical reagents are directed through the flow cell for coupling to deprotected regions, as well as for washing and other operations.
  • the substrates fabricated by the synthesis system are optionally diced into smaller chips.
  • the output of the synthesis system is a chip ready for application of a target sample.
  • a biological source 112 is, for example, tissue from a plant or animal.
  • Various processing steps are applied to material from biological source 112 by a sample preparation system 114. These steps may include e.g., isolation of mRNA, precipitation of the mRNA to increase concentration, etc, synthesis of cDNA from mRNA, PCR amplification of fragments of interest.
  • the result of the various processing steps is a target ready for application to the chips produced by the synthesis system 110.
  • the prepared samples include monomer nucleotide sequences such as RNA or
  • the nucleotides may or may not bond to the probes.
  • the nucleotides have been tagged with fluoroscein labels to determine which probes have bonded to nucleotide sequences from the sample.
  • the prepared samples will be placed in a scanning system 118.
  • Scanning system 118 includes a detection device such as a confocal microscope or CCD (charge-coupled device) that is used to detect the location where labeled receptors have bound to the substrate.
  • the output of scanning system 118 is an image file(s) indicating, in the case of fluorescein labeled receptor, the fluorescence intensity (photon counts or other related measurements, such as voltage) as a function of position on the substrate.
  • image files also form a part of chip design database 102. Since higher photon counts will be observed where the labeled receptor has bound more strongly to the array of polymers, and since the monomer sequence of the polymers on the substrate is known as a function of position, it becomes possible to determine the sequence(s) of polymer(s) on the substrate that are complementary to the receptor.
  • the image files and the design of the chips are input to an analysis system 120 that, e.g., calls base sequences, or determines expression levels of genes or expressed sequence tags.
  • the expression level of a gene or EST is herein understood to be the concentration within a sample of mRNA or protein that would result from the transcription of the gene or EST.
  • Such analysis techniques are disclosed in WO97/10365, the contents of which are herein incorporated by reference.
  • Base calling techniques are described in WO 95/11995, the contents of which are herein incorporated by reference.
  • Chip design system 104, analysis system 120 and control portions of exposure system 116, sample preparation system 114, and scanning system 118 may be appropriately programmed computers such as a Sun workstation or IBM-compatible PC.
  • An independent computer for each system may perform the computer-implemented functions of these systems or one computer may combine the computerized functions of two or more systems.
  • One or more computers may maintain chip design database 102 independent of the computers operating the systems of Fig. 1 or chip design database 102 may be fully or partially maintained by these computers.
  • Fig. 2A depicts a block diagram of a host computer system 10 suitable for implementing the present invention.
  • Host computer system 210 includes a bus 212 which interconnects major subsystems such as a central processor 214, a system memory 216 (typically RAM), an input/output (I/O) adapter 218, an external device such as a display screen 224 via a display adapter 226, a keyboard 232 and a mouse 234 via an I/O adapter 218, a SCSI host adapter 236, and a floppy disk drive 238 operative to receive a floppy disk 240.
  • I/O input/output
  • SCSI host adapter 236 may act as a storage interface to a fixed disk drive 242 or a CD- ROM player 244 operative to receive a CD-ROM 246.
  • Fixed disk 244 may be a part of host computer system 210 or may be separate and accessed through other interface systems.
  • a network interface 248 may provide a direct connection to a remote server via a telephone link or to the Internet.
  • Network interface 248 may also connect to a local area network (LAN) or other network interconnecting many computer systems. Many other devices or subsystems (not shown) may be connected in a similar manner.
  • LAN local area network
  • Fig. 2A it is not necessary for all of the devices shown in Fig. 2A to be present to practice the present invention, as discussed below.
  • the devices and subsystems may be interconnected in different ways from that shown in Fig. 2A.
  • the operation of a computer system such as that shown in Fig. 2A is readily known in the art and is not discussed in detail in this application.
  • Code to implement the present invention may be operably disposed or stored in computer-readable storage media such as system memory 216, fixed disk 242, CD- ROM 246, or floppy disk 240.
  • Fig. 2B depicts a network 260 interconnecting multiple computer systems 210.
  • Network 260 may be a local area network (LAN), wide area network (WAN), etc.
  • Bioinformatics database 102 and the computer-related operations of the other elements of Fig. 2B may be divided amongst computer systems 210 in any way with network 260 being used to communicate information among the various computers.
  • Portable storage media such as floppy disks may be used to carry information between computers instead of network 260.
  • Chip design database 102 is preferably a relational database with a complex internal structure.
  • the structure and contents of chip design database 102 will be described with reference to a logical model that describes the contents of tables of the database as well as interrelationships among the tables.
  • a visual depiction of this model will be an Entity Relationship Diagram (ERD) which includes entities, relationships, and attributes.
  • ERP Entity Relationship Diagram
  • a detailed discussion of ERDs is found in "ERwin version 3.0 Methods Guide” available from Logic Works, Inc. of Princeton, NJ, the contents of which are herein incorporated by reference.
  • Those of skill in the art will appreciate that automated tools such as Developer 2000 available from Oracle will convert the ERD from Fig. 4 directly into executable code such as SQL code for creating and operating the database.
  • FIG. 3 is a key to the ERD that will be used to describe the contents of chip design database 102.
  • a representative table 302 includes one or more key attributes 304 and one or more non-key attributes 306.
  • Representative table 302 includes one or more records where each record includes fields corresponding to the listed attributes. The contents of the key fields taken together identify an individual record.
  • each table is represented by a rectangle divided by a horizontal line. The fields or attributes above the line are key while the fields or attributes below the line are non-key.
  • An identifying relationship 308 signifies that the key attribute of a parent table 310 is also a key attribute of a child table 312.
  • a non-identifying relationship 314 signifies that the key attribute of a parent table 316 is also a non-key attribute of a child table 318. Where (FK) appears in parenthesis, it indicates that an attribute of one table is a key attribute of another table. For both the non-identifying and the identifying relationship, one record in the parent table corresponds to one or more records in the child table.
  • chip design database 102 may be understood as providing a relational structure among genomic items, sequence items, and tiling items, as these terms are defined herein by use of example.
  • Genes are characterized by their sequence, location on the genome, and function.
  • Genomic items are herein defined as references to genes, gene clusters, expressed sequence tags (ESTs), and EST clusters by location and/or function but not by sequence.
  • Sequence items are herein defined to be any oligonucleotide sequence or group of oligonucleotide sequences that may or may not by itself have biological meaning.
  • a sequence item may be a long sequence of genomic DNA including more than one exon of biological significance. Alternatively, an exon may include many sequence items.
  • a genomic item may have multiple associated sequence items or groups of sequence items because of changes of sequence information stored in public genomic databases. Genomic items and sequence items are tracked separately by database 102. There is a many-to-many relationship between genomic items and sequence items which is captured by the internal structure of chip design database 102. Tiling items represent groupings of probes on a chip.
  • a tiling item may be a pair of group of pairs of match and mismatch probes for an expression analysis chip.
  • a tiling item may be an atom including a group of probes designed to detect a mutation or call a base at a particular base position. Tiling items are designed to interrogate sequence items, e.g., determine expression or call bases.
  • a single tiling item may be used to interrogate more than one sequence item.
  • a sequence item may identify a group of sequences or a single sequence that is longer than the length of a probe.
  • certain difficult sequences e.g., sequences including long runs of the same base, may require more than one tiling item for interrogation.
  • Tiling items include probe pair sets.
  • a probe pair set represents a single sequence on a chip and include probe pairs.
  • Chip design database 102 thus enables one to follow the various interrelationships described above and, e.g., associate a particular probe on a chip with the associated probe pair, probe pair set, tiling item, sequence item, genomic item, etc.
  • the associated genomic item may be a gene cluster associated with a particular gene and an accession number within some biological database. All of these highly complex relationships are preferably captured within chip design database 102.
  • Chip design database 102 also preferably includes information such as the tiling items contained within any particular chip design. There also may be information about customer orders for a particular chip design including what sequences were to be tested by a particular chip design, who ordered the chip design, etc.
  • Chip design database 102 is a highly useful tool in designing and tracking existing chip designs.
  • One application is storing intermediate data about genomic items, sequence items, etc. that is input or generated during the course of generating a chip design.
  • scientists may request that particular genes or sequences be investigated.
  • An intermediate step in determining the chip design will be populating chip design database 102 with the information identifying genes or sequences to be investigated. Since chip design database 102 preserves the information about the genomic items that are investigated by a particular chip design, it is also very useful in finding existing chip designs that are capable of servicing new requests.
  • chip design database 102 may be used after chip design is complete to answer questions about which genomic items and/or sequence items are interrogated by a particular probe or tiling item. Database Model
  • Fig. 4 is an entity relationship diagram (ERD) showing elements of chip design database 102 according to one embodiment of the present invention.
  • ERP entity relationship diagram
  • Each rectangle in the diagram corresponds to a table in database 102.
  • the title of the table is listed above the rectangle.
  • columns of the table are listed.
  • Above a horizontal line within each rectangle are listed key columns, columns whose contents are used to identify individual records in the table. Below this horizontal line are the names of non-key columns.
  • the lines between the rectangles identify the relationships between records of one table and records of another table.
  • the tables of database 102 may be understood as belonging to different groups that relate to purpose.
  • each table is denoted with a capital letter "A" through “F” to denote membership in a group.
  • Group A includes sequence and biological data.
  • Group B includes design request information.
  • Group C includes chip design information such as which probes are included and how they are laid out.
  • Group D includes design specification information including information used in selecting probes.
  • Group E includes information about compliance to customer contracts for chip design and production.
  • Group F includes information about sequences requested but not included in a final chip design because of difficulty in selecting probes that would be effective in investigating them.
  • the interrelationships and general contents of the tables of database 102 will be described first. Then a chart will be presented listing and describing all of the fields of the various tables.
  • a tiling item table 402 lists the various tiling items. Each record in tiling item table 402 identifies a tiling item for a particular chip design. Each tiling item has an associated tiling item type listed in a tiling item type table 406. Examples of tiling item type include "probe pairs" which would identify a perfect match ⁇ mismatch probe pair or "atom" which would indicate a group of probes used for determining a mutation or calling a base at a particular base position. Each tiling item has one or more associated probes which are listed in a probe table 408. A tiling item may itself be an aggregation of other tiling items.
  • a tiling composition table 409 includes records that associate aggregate tiling items with the tiling items they include.
  • a probe role record in a probe role table 410 Associated with each probe listed in probe table 408 is a probe role record in a probe role table 410.
  • the probe role record tells, e.g., if a particular probe in a perfect match mismatch pair is itself the perfect match or the mismatch.
  • a probe specification record in a probe specification table 412.
  • the probe specification record tells the length of the probe and the orientation of the probe.
  • the orientation of the probe is identified within the probe specification record by reference to a record in a sense type table 414 which lists both orientations.
  • a chip design table 416 lists chip designs. Associated with each chip design is a plurality of tiling items in tiling item table 402. Also associated with each chip design is a chip design type as listed in a chip design type table 418. Examples of chip design types are "expression analysis" or "mutation detection.” Each chip design may have many associated chip design names listed in a chip design name table 420. These names may include informal names used within the organization or formal names used in formal inter- organization communications. Chip designs may be aggregated into chip design sets which are listed in a chip composition table 422. Each record of chip composition table 422 identifies a chip design set which may include more than one chip design listed in chip design table 416.
  • a chip design set may characterize a group of chips used together for a particular purpose such as identifying expression of oncogenes or tumor suppressors in humans.
  • An exception table 424 lists sequences whose investigation was requested but for which optimal probes were not included in the design. Each exception is associated with a particular combination of sequence and tiling item and has an associated exception type listed in an exception type table 426.
  • One type of exception referred to as an "R” exception is noted when preferred rules for probe selection have not been followed because they would not result in an adequate set of probes in the chip design for a particular sequence.
  • An "S” exception denotes that the sequence is very similar to another sequence and that sequences had to be grouped together to find acceptable probe sets so that certain probes interrogate more than one sequence.
  • An “I” exception indicates that the probe set is incomplete, although the probes that are included in the set interrogating the sequence are of high quality.
  • a “B” exception indicates that all probe selection rules have been dropped and that the probes are of low quality.
  • a “G” indicates that the sequence overlaps with another sequence.
  • sequence item table 426 that lists all the sequence items of chip design database 102. Associated with each listed sequence item is a sequence type from sequence type table 428. Examples of sequence type include "sequence" and "group of sequences.”
  • sequence composition table 430 is used to aggregate sequences into groups of sequences. Each group listed in sequence composition table 430 has associated sequences in sequence item table 426.
  • sequence derivation table 432 which lists derivations used to transform one sequence listed in sequence item table 426 into another. Each derivation has a derivation type listed in a derivation type table 434. Examples of derivation types include "removal of ambiguities," or "change in GenBank information.”
  • An allele table 436 lists polymorphisms for some of the sequences listed in sequence item table 432.
  • a sequence overlap table 438 lists overlaps between sequences of sequence item table 426. These overlaps are important to know for the probe selection process. The overlaps are determined by a process known as blast comparison. The result of a blast comparison is a description of the match quality between the compared sequences. This match quality is stored in sequence overlap table 438.
  • sequences may be the basis for creating tiling items. Sequence information is also the basis for pruning the set of probes that are included in a chip design. Pruning is a step of probe selection. Objectives of pruning may include: assuring that no probe is a duplicate of another probe in a probe pair set, assuring that no probe is the same as any other probe in a chip or set of chips, or assuring that a probe is not a duplicate of any probe that would be used to interrogate a set of sequences larger than the set investigated by a chip or set of chips. For example, it may be useful once the entire human genome is known to prune probe sets so that no probe is used that would interrogate more than one sequence in the genome.
  • chip database 102 provides a pruning set table 440 which lists pruning sets. Each pruning set has an associated chip design in chip design table 416.
  • a pruning map table 442 lists correlations between particular sequence items and pruning sets and implements the many-to-many relation that exists between sequence item table 426 and pruning set table 440.
  • a genomic item table 444 lists genomic items. Each listed genomic item may be a gene or EST or an aggregate of genes or ESTs.
  • a genomic composition table 446 lists the relationships between aggregations of genes and/or ESTs and their components.
  • a genomic name table 448 lists names of genomes. Each name may apply to more than one genome. Similarly, each genome may have more than one name.
  • a genomic name map table 450 implements the many-to-many relationships between genomes and names.
  • a genomic type table 452 lists the various types of genome such as "gene,”
  • genomic item table 444 Each genomic item in genomic item table 444 has an associated genomic type in genomic type table 452.
  • a species table 454 lists the species associated with the genomic items. Each genomic item in genomic item table 444 has an associated species in species table 454. It is often useful to know the position of a genomic item in a chromosome.
  • a chromosome table 456 lists various chromosomes. Each record in a chromosome map table 458 indicates which chromosome a genomic item is located in and where on the chromosome the genomic item would be found.
  • biological database reference table 460 each include information as would be found in one database about one genomic item.
  • the databases themselves are listed in a biological database table 462. Representative databases include GenBank, Entrez, and TIGR.
  • Genomic items are themselves related to one another by functional homology. Genomic items may be grouped by the functions performed by proteins that result from their expression.
  • a homology function table 464 lists different functions in a cell.
  • a homology map table 466 lists associations between the listed homologies and genomic items listed in genomic item table 444.
  • Genomic items listed in genomic item table 444 may also have associated annotation information.
  • An annotation table 468 lists annotations for genomic items. Each record in an annotation map table 470 associates an annotation and a genomic item. A comment found in an annotation may be backed up by a citation to the literature listed in a citation table 472.
  • Genomic items may be grouped into sets corresponding to projects where each project has a particular investigative objective. For example one project may investigate genes relating to high blood pressure while another project investigates genes relating to breast cancer. Typically, a project will be the impetus for designing a chip or a set of chips.
  • a project table 476 lists such projects.
  • a project map table 478 lists associations between projects and genomic items and like the other map tables implements a many-to- many relationship between genomic items and projects.
  • the chip design process may originate with a project assignment which specifies genomic items, or may alternatively originate with a design request that specifies sequences to be interrogated by probes on the chip.
  • a design request table 480 lists such design requests. Each design request may have many associated design request items listed in a design request item table 482.
  • the records of design request item table 482 each identify a requested sequence item. All requested sequences may or may not fit in the final chip design. If a requested sequence is not found in a chip design, this is recorded in a reject map table 484.
  • Each record in reject map table 484 identifies a sequence that was requested to be included in a particular chip design but left out. Each such reject record has an associated reject type selected from the types listed in a reject type table 486.
  • each design request or project is a customer as listed in a customer table 488.
  • Each customer may have one or more associated design requests, annotations, or projects as listed in tables 480, 468, and 476 respectively.
  • a customer may also be the source of one or more sequence items as found in a sequence item table 426.
  • a source map table 490 implements the many-to-many relationship between sequence items and customers.
  • Each customer is associated with a site as recorded in a site table 492.
  • a design map table 493 lists associations between design requests and projects. Companies may have one or more sites and are listed in a company table 494.
  • Bio databases listed in biological database table 462 may be proprietary to companies listed in company table 494. By providing a relationship between these two tables, chip design database 102 allows the chip designer to keep track of genomic item information that should be kept proprietary to particular orderers.
  • Source map table 490 similarly assists in maintaining the necessary confidentiality for customer-originated sequence information.
  • a company may request specific probes to be included in a chip. These requests are listed in a probe request table 491.
  • An order limits table 493 lists the contractual limitations that apply to chip design work to be done for particular companies. For example, a company may be limited to investigate a certain number of genes per chip, or be limited to request a certain number of probes per chip.
  • a communications table 496 lists communications between the chip designer and customer about a particular design request. Each design request may have one or more associated communications. Each communication listed in communications table 496 has an associated communications type as listed in a communications type table 498. Different communication types may correspond to different stages in the process. For example, the different types may include "chip request,” “sequences updated,” “sequences incomplete,” etc.
  • a classification table 500 lists classifications of item requests. Such classifications represent functional hierarchies. Classifications may include, e.g., tissue types or protein family names.
  • a classification map table 502 associates item requests with classifications. The many-to-many relationship between genomic items and sequence items is implemented by a sequence map table 504 which lists associations between genomic items and sequence items. The many-to-many relationship between sequence items and tiling items and thus probes is implemented by a sequence used map 506 which lists associations between sequence items and tiling items.
  • a control map table 508 similarly implements a many-to-many relationship between sequence items and tiling types.

Abstract

A database model is provided which organizes information interrelating probes (408, 410, 412, 491) on a chip, genomic items (444, 446, 448, 452) investigated by the chip, and sequence information (426, 428, 430, 432, 438, 504, 506) relating to the design of the chip (416).

Description

METHOD AND SYSTEM FOR PROVIDING A PROBE ARRAY
CHIP DESIGN DATABASE
CROSS-REFERENCE TO RELATED APPLICATIONS
The present application claims priority from U.S. Prov. App. No. 60/053,842 filed July 25, 1997, entitled COMPREHENSIVE BIO-INFORMATICS DATABASE, from U.S. Prov. App. No. 60/069,198 filed on December 11, 1997, entitled COMPREHENSIVE DATABASE FOR BIOINFORMATICS , and from U.S. Prov. App. No. 60/069,436, entitled GENE EXPRESSION AND EVALUATION SYSTEM, filed on December 11, 1997. The contents of all three provisional applications are herein incorporated by reference. The subject matter of the present application is related to the subject matter of the following three co-assigned applications filed on the same day as the present application: GENE EXPRESSION AND EVALUATION SYSTEM (Attorney Docket No. 018547- 035010), METHOD AND APPARATUS FOR PROVIDING A BIOINFORMATICS DATABASE (Attorney Docket No. 018547-033810), METHOD AND SYSTEM FOR PROVIDING A POLYMORPHISM DATABASE (Attorney Docket No. 018547-033820). The contents of these three applications are herein incorporated by reference.
BACKGROUND OF THE INVENTION
The present invention relates to the collection and storage of information pertaining to chips for processing samples.
Devices and computer systems for forming and using arrays of materials on a substrate are known. For example, PCT application WO92/10588, incorporated herein by reference for all purposes, describes techniques for sequencing or sequence checking nucleic acids and other materials. Arrays for performing these operations may be formed in arrays according to the methods of, for example, the pioneering techniques disclosed in U.S. Patent No. 5,143,854 and U.S. Patent No. 5,571,639, both incorporated herein by reference for all purposes. According to one aspect of the techniques described therein, an array of nucleic acid probes is fabricated at known locations on a chip or substrate. A fluorescently labeled nucleic acid is then brought into contact with the chip and a scanner generates an image file indicating the locations where the labeled nucleic acids bound to the chip. Based upon the identities of the probes at these locations, it becomes possible to extract information such as the monomer sequence of DNA or RNA. Such systems have been used to form, for example, arrays of DNA that may be used to study and detect mutations relevant to cystic fibrosis, the P53 gene (relevant to certain cancers), HIV, and other genetic characteristics.
Computer-aided techniques for monitoring gene expression using such arrays of probes have also been developed as disclosed in U.S. Patent Application No. 08/828,952 and PCT publication No. WO 97/10365, the contents of which are herein incorporated by reference. Many disease states are characterized by differences in the expression levels of various genes either through changes in the copy number of the genetic DNA or through changes in levels of transcription (e.g., through control of initiation, provision of RNA precursors, RNA processing, etc.) of particular genes. For example, losses and gains of genetic material play an important role in malignant transformation and progression. Furthermore, changes in the expression (transcription) levels of particular genes (e.g., oncogenes or tumor suppressors), serve as signposts for the presence and progression of various cancers. As can be seen, the probe array chips are designed to answer questions about genomic items, herein defined to include genes, expressed sequence tags (ESTs), gene clusters, and EST clusters. Associated with information about genomic items is genetic sequence information concerning the base sequences of genomic items. Probes are designed and selected for inclusion on a chip based on: 1) the identity of the genomic items to be investigated by the chip, 2) the sequence information associated with those genomic information, and 3) the type of information sought, e.g., expression analysis, polymorphism analysis, etc. The interrelationships, however, among probes, genomic items, and sequence information are, however, extremely complex, greatly complicating the tasks of designing chips, effectively exploiting chips that have already been designed, and efficiently interpreting the information generated by application of the chips.
Moreover, it is contemplated that the operations of chip design, construction, and application will occur on a very large scale. The quantity of information related to chip design to store and correlate is vast. What is needed is a system and method suitable for storing and organizing large quantities of information used in conjunction with the design of probe array chips.
SUMMARY OF THE INVENTION
The present invention provides systems and method for organizing information relating to the design of polymer probe array chips including oligonucleotide array chips. A database model is provided which organizes information interrelating probes on a chip, genomic items investigated by the chip, and sequence information relating to the design of the chip. The model is readily translatable into database languages such as SQL. The database model scales to permit storage of information about large numbers of chips having complex designs.
According to one aspect of the present invention, a computer-readable storage medium is provided. A relational database is stored on this medium. The relational database includes: a probe table including a plurality of probe records, each of the probe records specifying a polymer probe for use in one or more polymer probe arrays, a sequence item table including a plurality of sequence item records, each of the sequence item records specifying a nucleotide sequence to be investigated in the one or more polymer probe arrays, wherein there is a many-to-many relationship between the probe records and the sequence item records.
A further understanding of the nature and advantages of the inventions herein may be realized by reference to the remaining portions of the specification and the attached drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
Fig. 1 illustrates an overall system and process for forming and analyzing arrays of biological materials such as DNA or RNA.
Fig. 2 A illustrates a computer system suitable for use in conjunction with the overall system of Fig. 1. Fig. 2B illustrates a computer network suitable for use in conjunction with the overall system of Fig. 1.
Fig. 3 illustrates a key for interpreting a database model. Fig. 4 illustrates a database model for maintaining information for the system and process of Fig. 1 according to one embodiment of the present invention.
DESCRIPTION OF SPECIFIC EMBODIMENTS Biological Material Analysis System
One embodiment of the present invention operates in the context of a system for analyzing biological or other materials using arrays that themselves include probes that may be made of biological materials such as RNA or DNA. The VLSIPS™ and GeneChip™ technologies provide methods of making and using very large arrays of polymers, such as nucleic acids, on chips. See U.S. Patent No. 5,143,854 and PCT Patent Publication Nos. WO 90/15070 and 92/10092, each of which is hereby incorporated by reference for all purposes. Nucleic acid probes on the chip are used to detect complementary nucleic acid sequences in a sample nucleic acid of interest (the "target" nucleic acid).
It should be understood that the probes need not be nucleic acid probes but may also be other polymers such as peptides. Peptide probes may be used to detect the concentration of peptides, polypeptides, or polymers in a sample. The probes must be carefully selected to have bonding affinity to the compound whose concentration they are to be used to measure.
Fig. 1 illustrates an overall system 100 for forming and analyzing arrays of biological materials such as RNA or DNA. A part of system 100 is a chip design database 102. Chip design database 102 includes information about chip designs and the purposes of chips. Chip design database 102 facilitates large scale design, construction, and processing of chips.
A chip design system 104 is used to design arrays of polymers such as biological polymers such as RNA or DNA. Chip design system 104 may be, for example, an appropriately programmed Sun Workstation or personal computer or workstation, such as an IBM PC equivalent, including appropriate memory and a CPU. Chip design system 104 obtains inputs from a user regarding chip design objectives including characteristics of genes of interest, and other inputs regarding the desired features of the array. All of this information may be stored in chip design database 102. Optionally, chip design system 104 may obtain information regarding a specific genetic sequence of interest from chip design database 102 or from external databases such as GenBank. The output of chip design system 104 is a set of chip design computer files in the form of, for example, a switch matrix, as described in PCT application WO 92/10092, and other associated computer files. The chip design computer files form a part of chip design database 102. Systems for designing chips for sequence determination and expression analysis are disclosed in U.S. Patent No. 5,571,639 and in PCT application WO 97/10365, the contents of which are herein incorporated by reference.
The chip design files are input to a mask design system (not shown) that designs the lithographic masks used in the fabrication of arrays of molecules such as DNA. The mask design system designs the lithographic masks used in the fabrication of probe arrays. The mask design system generates mask design files that are then used by a mask construction system (not shown) to construct masks or other synthesis patterns such as chrome-on-glass masks for use in the fabrication of polymer arrays.
The masks are used in a synthesis system (not shown). The synthesis system includes the necessary hardware and software used to fabricate arrays of polymers on a substrate or chip. The synthesis system includes a light source and a chemical flow cell on which the substrate or chip is placed. A mask is placed between the light source and the substrate/chip, and the two are translated relative to each other at appropriate times for deprotection of selected regions of the chip. Selected chemical reagents are directed through the flow cell for coupling to deprotected regions, as well as for washing and other operations. The substrates fabricated by the synthesis system are optionally diced into smaller chips. The output of the synthesis system is a chip ready for application of a target sample.
Information about the mask design, mask construction, probe array synthesis , and analysis systems is presented by way of background. A biological source 112 is, for example, tissue from a plant or animal. Various processing steps are applied to material from biological source 112 by a sample preparation system 114. These steps may include e.g., isolation of mRNA, precipitation of the mRNA to increase concentration, etc, synthesis of cDNA from mRNA, PCR amplification of fragments of interest. The result of the various processing steps is a target ready for application to the chips produced by the synthesis system 110. The prepared samples include monomer nucleotide sequences such as RNA or
DNA. When the sample is applied to the chip by a sample exposure system 116, the nucleotides may or may not bond to the probes. The nucleotides have been tagged with fluoroscein labels to determine which probes have bonded to nucleotide sequences from the sample. The prepared samples will be placed in a scanning system 118. Scanning system 118 includes a detection device such as a confocal microscope or CCD (charge-coupled device) that is used to detect the location where labeled receptors have bound to the substrate. The output of scanning system 118 is an image file(s) indicating, in the case of fluorescein labeled receptor, the fluorescence intensity (photon counts or other related measurements, such as voltage) as a function of position on the substrate. These image files also form a part of chip design database 102. Since higher photon counts will be observed where the labeled receptor has bound more strongly to the array of polymers, and since the monomer sequence of the polymers on the substrate is known as a function of position, it becomes possible to determine the sequence(s) of polymer(s) on the substrate that are complementary to the receptor.
The image files and the design of the chips are input to an analysis system 120 that, e.g., calls base sequences, or determines expression levels of genes or expressed sequence tags. The expression level of a gene or EST is herein understood to be the concentration within a sample of mRNA or protein that would result from the transcription of the gene or EST. Such analysis techniques are disclosed in WO97/10365, the contents of which are herein incorporated by reference. Base calling techniques are described in WO 95/11995, the contents of which are herein incorporated by reference. Chip design system 104, analysis system 120 and control portions of exposure system 116, sample preparation system 114, and scanning system 118 may be appropriately programmed computers such as a Sun workstation or IBM-compatible PC. An independent computer for each system may perform the computer-implemented functions of these systems or one computer may combine the computerized functions of two or more systems. One or more computers may maintain chip design database 102 independent of the computers operating the systems of Fig. 1 or chip design database 102 may be fully or partially maintained by these computers.
Fig. 2A depicts a block diagram of a host computer system 10 suitable for implementing the present invention. Host computer system 210 includes a bus 212 which interconnects major subsystems such as a central processor 214, a system memory 216 (typically RAM), an input/output (I/O) adapter 218, an external device such as a display screen 224 via a display adapter 226, a keyboard 232 and a mouse 234 via an I/O adapter 218, a SCSI host adapter 236, and a floppy disk drive 238 operative to receive a floppy disk 240. SCSI host adapter 236 may act as a storage interface to a fixed disk drive 242 or a CD- ROM player 244 operative to receive a CD-ROM 246. Fixed disk 244 may be a part of host computer system 210 or may be separate and accessed through other interface systems. A network interface 248 may provide a direct connection to a remote server via a telephone link or to the Internet. Network interface 248 may also connect to a local area network (LAN) or other network interconnecting many computer systems. Many other devices or subsystems (not shown) may be connected in a similar manner.
Also, it is not necessary for all of the devices shown in Fig. 2A to be present to practice the present invention, as discussed below. The devices and subsystems may be interconnected in different ways from that shown in Fig. 2A. The operation of a computer system such as that shown in Fig. 2A is readily known in the art and is not discussed in detail in this application. Code to implement the present invention, may be operably disposed or stored in computer-readable storage media such as system memory 216, fixed disk 242, CD- ROM 246, or floppy disk 240.
Fig. 2B depicts a network 260 interconnecting multiple computer systems 210. Network 260 may be a local area network (LAN), wide area network (WAN), etc. Bioinformatics database 102 and the computer-related operations of the other elements of Fig. 2B may be divided amongst computer systems 210 in any way with network 260 being used to communicate information among the various computers. Portable storage media such as floppy disks may be used to carry information between computers instead of network 260.
Overall Description of Database Chip design database 102 is preferably a relational database with a complex internal structure. The structure and contents of chip design database 102 will be described with reference to a logical model that describes the contents of tables of the database as well as interrelationships among the tables. A visual depiction of this model will be an Entity Relationship Diagram (ERD) which includes entities, relationships, and attributes. A detailed discussion of ERDs is found in "ERwin version 3.0 Methods Guide" available from Logic Works, Inc. of Princeton, NJ, the contents of which are herein incorporated by reference. Those of skill in the art will appreciate that automated tools such as Developer 2000 available from Oracle will convert the ERD from Fig. 4 directly into executable code such as SQL code for creating and operating the database.
Fig. 3 is a key to the ERD that will be used to describe the contents of chip design database 102. A representative table 302 includes one or more key attributes 304 and one or more non-key attributes 306. Representative table 302 includes one or more records where each record includes fields corresponding to the listed attributes. The contents of the key fields taken together identify an individual record. In the ERD, each table is represented by a rectangle divided by a horizontal line. The fields or attributes above the line are key while the fields or attributes below the line are non-key. An identifying relationship 308 signifies that the key attribute of a parent table 310 is also a key attribute of a child table 312. A non-identifying relationship 314 signifies that the key attribute of a parent table 316 is also a non-key attribute of a child table 318. Where (FK) appears in parenthesis, it indicates that an attribute of one table is a key attribute of another table. For both the non-identifying and the identifying relationship, one record in the parent table corresponds to one or more records in the child table.
At the highest level, chip design database 102 may be understood as providing a relational structure among genomic items, sequence items, and tiling items, as these terms are defined herein by use of example. Genes are characterized by their sequence, location on the genome, and function. Genomic items are herein defined as references to genes, gene clusters, expressed sequence tags (ESTs), and EST clusters by location and/or function but not by sequence. Sequence items are herein defined to be any oligonucleotide sequence or group of oligonucleotide sequences that may or may not by itself have biological meaning. A sequence item may be a long sequence of genomic DNA including more than one exon of biological significance. Alternatively, an exon may include many sequence items. Also, a genomic item may have multiple associated sequence items or groups of sequence items because of changes of sequence information stored in public genomic databases. Genomic items and sequence items are tracked separately by database 102. There is a many-to-many relationship between genomic items and sequence items which is captured by the internal structure of chip design database 102. Tiling items represent groupings of probes on a chip. A tiling item may be a pair of group of pairs of match and mismatch probes for an expression analysis chip. For sequencing chips, a tiling item may be an atom including a group of probes designed to detect a mutation or call a base at a particular base position. Tiling items are designed to interrogate sequence items, e.g., determine expression or call bases. However, a single tiling item may be used to interrogate more than one sequence item. For example, consider that a sequence item may identify a group of sequences or a single sequence that is longer than the length of a probe. Conversely, certain difficult sequences, e.g., sequences including long runs of the same base, may require more than one tiling item for interrogation. There is thus a many-to-many relationship between sequence item and tiling item and this relation is also captured by the internal design of chip design database 102.
Tiling items include probe pair sets. A probe pair set represents a single sequence on a chip and include probe pairs. Chip design database 102 thus enables one to follow the various interrelationships described above and, e.g., associate a particular probe on a chip with the associated probe pair, probe pair set, tiling item, sequence item, genomic item, etc. The associated genomic item may be a gene cluster associated with a particular gene and an accession number within some biological database. All of these highly complex relationships are preferably captured within chip design database 102.
Chip design database 102 also preferably includes information such as the tiling items contained within any particular chip design. There also may be information about customer orders for a particular chip design including what sequences were to be tested by a particular chip design, who ordered the chip design, etc.
Applications of Chip Design Database
Chip design database 102 is a highly useful tool in designing and tracking existing chip designs. One application is storing intermediate data about genomic items, sequence items, etc. that is input or generated during the course of generating a chip design. Scientists may request that particular genes or sequences be investigated. An intermediate step in determining the chip design will be populating chip design database 102 with the information identifying genes or sequences to be investigated. Since chip design database 102 preserves the information about the genomic items that are investigated by a particular chip design, it is also very useful in finding existing chip designs that are capable of servicing new requests. Also, chip design database 102 may be used after chip design is complete to answer questions about which genomic items and/or sequence items are interrogated by a particular probe or tiling item. Database Model
Fig. 4 is an entity relationship diagram (ERD) showing elements of chip design database 102 according to one embodiment of the present invention. Each rectangle in the diagram corresponds to a table in database 102. For each rectangle, the title of the table is listed above the rectangle. Within each rectangle, columns of the table are listed. Above a horizontal line within each rectangle are listed key columns, columns whose contents are used to identify individual records in the table. Below this horizontal line are the names of non-key columns. The lines between the rectangles identify the relationships between records of one table and records of another table. First, the relationships among the various tables will be described. Then, the contents of each table will be discussed in detail.
The tables of database 102 may be understood as belonging to different groups that relate to purpose. In Fig. 4, each table is denoted with a capital letter "A" through "F" to denote membership in a group. Group A includes sequence and biological data. Group B includes design request information. Group C includes chip design information such as which probes are included and how they are laid out. Group D includes design specification information including information used in selecting probes. Group E includes information about compliance to customer contracts for chip design and production. Group F includes information about sequences requested but not included in a final chip design because of difficulty in selecting probes that would be effective in investigating them. The interrelationships and general contents of the tables of database 102 will be described first. Then a chart will be presented listing and describing all of the fields of the various tables.
A tiling item table 402 lists the various tiling items. Each record in tiling item table 402 identifies a tiling item for a particular chip design. Each tiling item has an associated tiling item type listed in a tiling item type table 406. Examples of tiling item type include "probe pairs" which would identify a perfect match ~ mismatch probe pair or "atom" which would indicate a group of probes used for determining a mutation or calling a base at a particular base position. Each tiling item has one or more associated probes which are listed in a probe table 408. A tiling item may itself be an aggregation of other tiling items. A tiling composition table 409 includes records that associate aggregate tiling items with the tiling items they include. Associated with each probe listed in probe table 408 is a probe role record in a probe role table 410. The probe role record tells, e.g., if a particular probe in a perfect match mismatch pair is itself the perfect match or the mismatch. Further associated with each probe is a probe specification record in a probe specification table 412. The probe specification record tells the length of the probe and the orientation of the probe. The orientation of the probe (sense or antisense) is identified within the probe specification record by reference to a record in a sense type table 414 which lists both orientations.
A chip design table 416 lists chip designs. Associated with each chip design is a plurality of tiling items in tiling item table 402. Also associated with each chip design is a chip design type as listed in a chip design type table 418. Examples of chip design types are "expression analysis" or "mutation detection." Each chip design may have many associated chip design names listed in a chip design name table 420. These names may include informal names used within the organization or formal names used in formal inter- organization communications. Chip designs may be aggregated into chip design sets which are listed in a chip composition table 422. Each record of chip composition table 422 identifies a chip design set which may include more than one chip design listed in chip design table 416. A chip design set may characterize a group of chips used together for a particular purpose such as identifying expression of oncogenes or tumor suppressors in humans. An exception table 424 lists sequences whose investigation was requested but for which optimal probes were not included in the design. Each exception is associated with a particular combination of sequence and tiling item and has an associated exception type listed in an exception type table 426. One type of exception, referred to as an "R" exception is noted when preferred rules for probe selection have not been followed because they would not result in an adequate set of probes in the chip design for a particular sequence. An "S" exception denotes that the sequence is very similar to another sequence and that sequences had to be grouped together to find acceptable probe sets so that certain probes interrogate more than one sequence. An "I" exception indicates that the probe set is incomplete, although the probes that are included in the set interrogating the sequence are of high quality. A "B" exception indicates that all probe selection rules have been dropped and that the probes are of low quality. A "G" indicates that the sequence overlaps with another sequence.
There is a sequence item table 426 that lists all the sequence items of chip design database 102. Associated with each listed sequence item is a sequence type from sequence type table 428. Examples of sequence type include "sequence" and "group of sequences." A sequence composition table 430 is used to aggregate sequences into groups of sequences. Each group listed in sequence composition table 430 has associated sequences in sequence item table 426.
There is a sequence derivation table 432 which lists derivations used to transform one sequence listed in sequence item table 426 into another. Each derivation has a derivation type listed in a derivation type table 434. Examples of derivation types include "removal of ambiguities," or "change in GenBank information." An allele table 436 lists polymorphisms for some of the sequences listed in sequence item table 432.
A sequence overlap table 438 lists overlaps between sequences of sequence item table 426. These overlaps are important to know for the probe selection process. The overlaps are determined by a process known as blast comparison. The result of a blast comparison is a description of the match quality between the compared sequences. This match quality is stored in sequence overlap table 438.
During the chip design process, sequences may be the basis for creating tiling items. Sequence information is also the basis for pruning the set of probes that are included in a chip design. Pruning is a step of probe selection. Objectives of pruning may include: assuring that no probe is a duplicate of another probe in a probe pair set, assuring that no probe is the same as any other probe in a chip or set of chips, or assuring that a probe is not a duplicate of any probe that would be used to interrogate a set of sequences larger than the set investigated by a chip or set of chips. For example, it may be useful once the entire human genome is known to prune probe sets so that no probe is used that would interrogate more than one sequence in the genome. The more that is pruned against, the higher the quality of the resulting chip design is since ambiguity in analysis results is greatly reduced. To facilitate pruning, chip database 102 provides a pruning set table 440 which lists pruning sets. Each pruning set has an associated chip design in chip design table 416. A pruning map table 442 lists correlations between particular sequence items and pruning sets and implements the many-to-many relation that exists between sequence item table 426 and pruning set table 440.
A genomic item table 444 lists genomic items. Each listed genomic item may be a gene or EST or an aggregate of genes or ESTs. A genomic composition table 446 lists the relationships between aggregations of genes and/or ESTs and their components. A genomic name table 448 lists names of genomes. Each name may apply to more than one genome. Similarly, each genome may have more than one name. A genomic name map table 450 implements the many-to-many relationships between genomes and names. A genomic type table 452 lists the various types of genome such as "gene,"
"gene cluster," "EST," and "EST cluster." Each genomic item in genomic item table 444 has an associated genomic type in genomic type table 452. A species table 454 lists the species associated with the genomic items. Each genomic item in genomic item table 444 has an associated species in species table 454. It is often useful to know the position of a genomic item in a chromosome. A chromosome table 456 lists various chromosomes. Each record in a chromosome map table 458 indicates which chromosome a genomic item is located in and where on the chromosome the genomic item would be found.
It is also useful to store information about database references for genomic items. The records of biological database reference table 460 each include information as would be found in one database about one genomic item. The databases themselves are listed in a biological database table 462. Representative databases include GenBank, Entrez, and TIGR.
Genomic items are themselves related to one another by functional homology. Genomic items may be grouped by the functions performed by proteins that result from their expression. A homology function table 464 lists different functions in a cell. A homology map table 466 lists associations between the listed homologies and genomic items listed in genomic item table 444.
Genomic items listed in genomic item table 444 may also have associated annotation information. An annotation table 468 lists annotations for genomic items. Each record in an annotation map table 470 associates an annotation and a genomic item. A comment found in an annotation may be backed up by a citation to the literature listed in a citation table 472.
Genomic items may be grouped into sets corresponding to projects where each project has a particular investigative objective. For example one project may investigate genes relating to high blood pressure while another project investigates genes relating to breast cancer. Typically, a project will be the impetus for designing a chip or a set of chips. A project table 476 lists such projects. A project map table 478 lists associations between projects and genomic items and like the other map tables implements a many-to- many relationship between genomic items and projects.
The chip design process may originate with a project assignment which specifies genomic items, or may alternatively originate with a design request that specifies sequences to be interrogated by probes on the chip. A design request table 480 lists such design requests. Each design request may have many associated design request items listed in a design request item table 482. The records of design request item table 482 each identify a requested sequence item. All requested sequences may or may not fit in the final chip design. If a requested sequence is not found in a chip design, this is recorded in a reject map table 484. Each record in reject map table 484 identifies a sequence that was requested to be included in a particular chip design but left out. Each such reject record has an associated reject type selected from the types listed in a reject type table 486. Associated with each design request or project is a customer as listed in a customer table 488. Each customer may have one or more associated design requests, annotations, or projects as listed in tables 480, 468, and 476 respectively. A customer may also be the source of one or more sequence items as found in a sequence item table 426. A source map table 490 implements the many-to-many relationship between sequence items and customers. Each customer is associated with a site as recorded in a site table 492.
There may also be associations between design requests and projects. Projects may have one or more associated design requests and design requests may have one or more associated projects. A design map table 493 lists associations between design requests and projects. Companies may have one or more sites and are listed in a company table 494.
Biological databases listed in biological database table 462 may be proprietary to companies listed in company table 494. By providing a relationship between these two tables, chip design database 102 allows the chip designer to keep track of genomic item information that should be kept proprietary to particular orderers. Source map table 490 similarly assists in maintaining the necessary confidentiality for customer-originated sequence information. A company may request specific probes to be included in a chip. These requests are listed in a probe request table 491. An order limits table 493 lists the contractual limitations that apply to chip design work to be done for particular companies. For example, a company may be limited to investigate a certain number of genes per chip, or be limited to request a certain number of probes per chip.
A communications table 496 lists communications between the chip designer and customer about a particular design request. Each design request may have one or more associated communications. Each communication listed in communications table 496 has an associated communications type as listed in a communications type table 498. Different communication types may correspond to different stages in the process. For example, the different types may include "chip request," "sequences updated," "sequences incomplete," etc.
A classification table 500 lists classifications of item requests. Such classifications represent functional hierarchies. Classifications may include, e.g., tissue types or protein family names. A classification map table 502 associates item requests with classifications. The many-to-many relationship between genomic items and sequence items is implemented by a sequence map table 504 which lists associations between genomic items and sequence items. The many-to-many relationship between sequence items and tiling items and thus probes is implemented by a sequence used map 506 which lists associations between sequence items and tiling items. A control map table 508 similarly implements a many-to-many relationship between sequence items and tiling types.
Database Contents
The contents of the tables introduced above will now be presented in greater detail in the following chart.
Figure imgf000017_0001
Figure imgf000018_0001
Figure imgf000020_0001
Figure imgf000021_0001
Figure imgf000022_0001
Figure imgf000023_0001
Figure imgf000024_0001
Figure imgf000025_0001
Figure imgf000026_0001
Figure imgf000027_0001
It is understood that the examples and embodiments described herein are for illustrative purposes only and that various modifications or changes in light thereof will be suggested to persons skilled in the art and are to be included within the spirit and purview of this application and scope of the appended claims. For example, tables may be deleted, contents of multiple tables may be consolidated, or contents of one or more tables may be distributed among more tables than described herein to improve query speeds and/or to aid system maintenance. Also, the database architecture and data models described herein are not limited to biological applications but may be used in any application. All publications, patents, and patent applications cited herein are hereby incorporated by reference.

Claims

WHAT IS CLAIMED IS: 1. A computer-readable storage medium having stored thereon: a relational database comprising: a probe table including a plurality of probe records, each of said probe records specifying a polymer probe for use in one or more polymer probe arrays; a sequence item table including a plurality of sequence item records, each of said sequence item records specifying a nucleotide sequence to be investigated in said one or more polymer probe arrays; and wherein there is a many-to-many relationship between said probe records and said sequence item records.
2. The medium of claim 1 wherein said relational database further comprises: a tiling item table including a plurality of tiling item records, each of said tiling item records having an aggregation relationship with said probe records so that each tiling item record has many associated probe records.
3. The medium of claim 1 wherein said relational database further comprises: a genomic item table including a plurality of genomic item records, each of said genomic item records specifying a genomic item to be investigated by said one or more polymer probe arrays; and wherein there is a many to many relationship between genomic item records and sequence item records.
4. The medium of claim 1 wherein said relational database further comprises: a chip design table including a plurality of chip design records, each of said chip design records specifying a design of a chip including a subset of said plurality of probe records.
5. A computer implemented method for operating a relational database comprising: creating a probe table including a plurality of probe records, each of said probe records specifying a polymer probe for use in one or more polymer probe arrays; creating a sequence item table including a plurality of sequence item records, each of said sequence item records specifying a nucleotide sequence to be investigated in said one or more polymer probe arrays; storing data in said probe table and said sequence item table; and wherein there is a many-to-many relationship between said probe records and said sequence item records.
6. The method of claim 5 further comprising the step of: creating a tiling item table including a plurality of tiling item records, each of said tiling item records having an aggregation relationship with said probe records so that each tiling item record has many associated probe records.
7. The method of claim 5 further comprising the step of: creating a genomic item table including a plurality of genomic item records, each of said genomic item records specifying a genomic item to be investigated by said one or more polymer probe arrays; and wherein there is a many to many relationship between genomic item records and sequence item records.
8. The method of claim 5 further comprising the step of: creating a chip design table including a plurality of chip design records, each of said chip design records specifying a design of a chip including a subset of said plurality of probe records.
9. A computer system comprising: a processor; and a storage medium storing a relational database accessible by said processor, said storage medium having stored thereon: a relational database comprising: a probe table including a plurality of probe records, each of said probe records specifying a polymer probe for use in one or more polymer probe arrays; a sequence item table including a plurality of sequence item records, each of said sequence item records specifying a nucleotide sequence to be investigated in said one or more polymer probe arrays; and wherein there is a many-to-many relationship between said probe records and said sequence item records.
PCT/US1998/015456 1997-07-25 1998-07-24 Method and system for providing a probe array chip design database WO1999005574A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2000504489A JP2001511550A (en) 1997-07-25 1998-07-24 Method and system for providing a probe array chip design database
EP98937126A EP0998697A4 (en) 1997-07-25 1998-07-24 Method and system for providing a probe array chip design database

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US5384297P 1997-07-25 1997-07-25
US60/053,842 1997-07-25
US6919897P 1997-12-11 1997-12-11
US6943697P 1997-12-11 1997-12-11
US60/069,198 1997-12-11
US60/069,436 1997-12-11

Publications (1)

Publication Number Publication Date
WO1999005574A1 true WO1999005574A1 (en) 1999-02-04

Family

ID=27368502

Family Applications (4)

Application Number Title Priority Date Filing Date
PCT/US1998/015151 WO1999005323A1 (en) 1997-07-25 1998-07-24 Gene expression and evaluation system
PCT/US1998/015456 WO1999005574A1 (en) 1997-07-25 1998-07-24 Method and system for providing a probe array chip design database
PCT/US1998/015458 WO1999005324A1 (en) 1997-07-25 1998-07-24 System for providing a polymorphism database
PCT/US1998/015469 WO1999005591A2 (en) 1997-07-25 1998-07-24 Method and apparatus for providing a bioinformatics database

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PCT/US1998/015151 WO1999005323A1 (en) 1997-07-25 1998-07-24 Gene expression and evaluation system

Family Applications After (2)

Application Number Title Priority Date Filing Date
PCT/US1998/015458 WO1999005324A1 (en) 1997-07-25 1998-07-24 System for providing a polymorphism database
PCT/US1998/015469 WO1999005591A2 (en) 1997-07-25 1998-07-24 Method and apparatus for providing a bioinformatics database

Country Status (6)

Country Link
US (10) US6484183B1 (en)
EP (4) EP1002264B1 (en)
JP (6) JP2001511529A (en)
AT (1) ATE264523T1 (en)
DE (1) DE69823206T2 (en)
WO (4) WO1999005323A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001013105A1 (en) * 1999-07-30 2001-02-22 Agy Therapeutics, Inc. Techniques for facilitating identification of candidate genes
WO2001080155A2 (en) * 2000-04-18 2001-10-25 Combimatrix Corporation Automated system and process for custom-designed biological array design and analysis
JP2002297617A (en) * 2001-03-29 2002-10-11 Hitachi Software Eng Co Ltd Method for displaying correlation between biopolymer and probe
US6919201B2 (en) * 2002-12-11 2005-07-19 Yokogawa Electric Corporation Biochip measuring method and measuring equipment
EP1978098A2 (en) 1999-12-10 2008-10-08 Invitrogen Corporation Use of multiple recombination sites with unique specificity in recombinational cloning

Families Citing this family (318)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1223831A (en) 1982-06-23 1987-07-07 Dean Engelhardt Modified nucleotides, methods of preparing and utilizing and compositions containing the same
US5989835A (en) 1997-02-27 1999-11-23 Cellomics, Inc. System for cell-based screening
US6826296B2 (en) * 1997-07-25 2004-11-30 Affymetrix, Inc. Method and system for providing a probe array chip design database
US6420108B2 (en) * 1998-02-09 2002-07-16 Affymetrix, Inc. Computer-aided display for comparative gene expression
US7068830B2 (en) * 1997-07-25 2006-06-27 Affymetrix, Inc. Method and system for providing a probe array chip design database
WO1999005323A1 (en) * 1997-07-25 1999-02-04 Affymetrix, Inc. Gene expression and evaluation system
US6349144B1 (en) * 1998-02-07 2002-02-19 Biodiscovery, Inc. Automated DNA array segmentation and analysis
US6990221B2 (en) * 1998-02-07 2006-01-24 Biodiscovery, Inc. Automated DNA array image segmentation and analysis
EP1066576A1 (en) * 1998-03-26 2001-01-10 Incyte Pharmaceuticals, Inc. System and methods for analyzing biomolecular sequences
US6324479B1 (en) * 1998-05-08 2001-11-27 Rosetta Impharmatics, Inc. Methods of determining protein activity levels using gene expression profiles
US6606622B1 (en) * 1998-07-13 2003-08-12 James M. Sorace Software method for the conversion, storage and querying of the data of cellular biological assays on the basis of experimental design
US6185561B1 (en) * 1998-09-17 2001-02-06 Affymetrix, Inc. Method and apparatus for providing and expression data mining database
US20040199544A1 (en) * 2000-11-02 2004-10-07 Affymetrix, Inc. Method and apparatus for providing an expression data mining database
CA2350587C (en) 1998-11-13 2004-04-27 Cellomics, Inc. Methods and system for efficient collection and storage of experimental data
US6453241B1 (en) * 1998-12-23 2002-09-17 Rosetta Inpharmatics, Inc. Method and system for analyzing biological response signal data
US20040111219A1 (en) * 1999-02-22 2004-06-10 Sandeep Gulati Active interferometric signal analysis in software
US6142681A (en) 1999-02-22 2000-11-07 Vialogy Corporation Method and apparatus for interpreting hybridized bioelectronic DNA microarray patterns using self-scaling convergent reverberant dynamics
US6245511B1 (en) * 1999-02-22 2001-06-12 Vialogy Corp Method and apparatus for exponentially convergent therapy effectiveness monitoring using DNA microarray based viral load measurements
US6136541A (en) 1999-02-22 2000-10-24 Vialogy Corporation Method and apparatus for analyzing hybridized biochip patterns using resonance interactions employing quantum expressor functions
US6507788B1 (en) * 1999-02-25 2003-01-14 Société de Conseils de Recherches et D'Applications Scientifiques (S.C.R.A.S.) Rational selection of putative peptides from identified nucleotide, or peptide sequences, of unknown function
US6215894B1 (en) * 1999-02-26 2001-04-10 General Scanning, Incorporated Automatic imaging and analysis of microarray biochips
JP2000258368A (en) * 1999-03-12 2000-09-22 Jeol Ltd X-ray microanalyzer having sound monitor function
DE60026190T2 (en) * 1999-03-30 2006-08-31 Fuji Photo Film Co., Ltd., Minami-Ashigara Method and device for the selective display of results and matching images
US6446072B1 (en) * 1999-04-13 2002-09-03 Michael D. Schulze Method of obtaining an electronically-stored financial document
US6651008B1 (en) 1999-05-14 2003-11-18 Cytokinetics, Inc. Database system including computer code for predictive cellular bioinformatics
US7151847B2 (en) 2001-02-20 2006-12-19 Cytokinetics, Inc. Image analysis of the golgi complex
US6743576B1 (en) 1999-05-14 2004-06-01 Cytokinetics, Inc. Database system for predictive cellular bioinformatics
US6876760B1 (en) 2000-12-04 2005-04-05 Cytokinetics, Inc. Classifying cells based on information contained in cell images
US20030228565A1 (en) * 2000-04-26 2003-12-11 Cytokinetics, Inc. Method and apparatus for predictive cellular bioinformatics
US6334099B1 (en) 1999-05-25 2001-12-25 Digital Gene Technologies, Inc. Methods for normalization of experimental data
JP3469504B2 (en) * 1999-06-01 2003-11-25 日立ソフトウエアエンジニアリング株式会社 Microarray chip and indexing method thereof
US6716579B1 (en) 1999-06-11 2004-04-06 Narayan Baidya Gene specific arrays, preparation and use
EP1185701A1 (en) * 1999-06-11 2002-03-13 Clingenix, Inc. Gene specific arrays and the use thereof
US7058517B1 (en) 1999-06-25 2006-06-06 Genaissance Pharmaceuticals, Inc. Methods for obtaining and using haplotype data
US6931396B1 (en) 1999-06-29 2005-08-16 Gene Logic Inc. Biological data processing
US6631211B1 (en) * 1999-07-08 2003-10-07 Perkinelmer Las, Inc. Interactive system for analyzing scatter plots
WO2001016860A2 (en) * 1999-08-27 2001-03-08 Iris Bio Technologies, Inc. Artificial intelligence system for genetic analysis
US7062076B1 (en) 1999-08-27 2006-06-13 Iris Biotechnologies, Inc. Artificial intelligence system for genetic analysis
EP1212599A2 (en) 1999-08-30 2002-06-12 Illumina, Inc. Methods for improving signal detection from an array
US7099502B2 (en) * 1999-10-12 2006-08-29 Biodiscovery, Inc. System and method for automatically processing microarrays
WO2001027857A2 (en) 1999-10-13 2001-04-19 Sequenom, Inc. Methods for generating databases and databases for identifying polymorphic genetic markers
AU1574801A (en) * 1999-10-26 2001-05-08 Genometrix Genomics Incorporated Process for requesting biological experiments and for the delivery of experimental information
WO2001056216A2 (en) * 2000-01-25 2001-08-02 Affymetrix, Inc. Method, system and computer software for providing a genomic web portal
US20030097222A1 (en) * 2000-01-25 2003-05-22 Craford David M. Method, system, and computer software for providing a genomic web portal
WO2001055951A2 (en) 2000-01-25 2001-08-02 Cellomics, Inc. Method and system for automated inference of physico-chemical interaction knowl edge
US7582420B2 (en) 2001-07-12 2009-09-01 Illumina, Inc. Multiplex nucleic acid reactions
US20050214825A1 (en) * 2000-02-07 2005-09-29 John Stuelpnagel Multiplex sample analysis on universal arrays
US8076063B2 (en) 2000-02-07 2011-12-13 Illumina, Inc. Multiplexed methylation detection methods
US7955794B2 (en) 2000-09-21 2011-06-07 Illumina, Inc. Multiplex nucleic acid reactions
US6770441B2 (en) * 2000-02-10 2004-08-03 Illumina, Inc. Array compositions and methods of making same
US6713258B2 (en) 2000-03-29 2004-03-30 Center For The Application Of Molecular Biology To International Agriculture (Cambia) Methods for genotyping by hybridization analysis
DE10015816A1 (en) * 2000-03-30 2001-10-18 Infineon Technologies Ag Biosensor chip
CA2405431A1 (en) * 2000-03-31 2001-10-11 Gene Logic, Inc. Gene expression profiles in esophageal tissue
US7020561B1 (en) 2000-05-23 2006-03-28 Gene Logic, Inc. Methods and systems for efficient comparison, identification, processing, and importing of gene expression data
US20030171876A1 (en) * 2002-03-05 2003-09-11 Victor Markowitz System and method for managing gene expression data
US7577683B2 (en) * 2000-06-08 2009-08-18 Ingenuity Systems, Inc. Methods for the construction and maintenance of a knowledge representation system
US6741986B2 (en) * 2000-12-08 2004-05-25 Ingenuity Systems, Inc. Method and system for performing information extraction and quality control for a knowledgebase
US6772160B2 (en) * 2000-06-08 2004-08-03 Ingenuity Systems, Inc. Techniques for facilitating information acquisition and storage
US6931326B1 (en) 2000-06-26 2005-08-16 Genaissance Pharmaceuticals, Inc. Methods for obtaining and using haplotype data
US20020152196A1 (en) * 2000-07-07 2002-10-17 Westbrook Carol A. cDNA database and biochip for analysis of hematopoietic tissue
JP3517644B2 (en) * 2000-07-13 2004-04-12 孝 五條堀 Method and system for displaying expression phenomenon of living organisms and program
US20020059326A1 (en) * 2000-07-25 2002-05-16 Derek Bernhart System, method, and computer program product for management of biological experiment information
NL1016034C2 (en) 2000-08-03 2002-02-08 Tno Method and system for identifying and quantifying chemical components of a mixture of materials to be investigated.
US7198924B2 (en) 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
AU2001290545A1 (en) * 2000-08-22 2002-03-04 Varro Technologies, Inc. Method and system for sharing biological information
JP2004512533A (en) 2000-08-22 2004-04-22 アフィメトリックス インコーポレイテッド Systems, methods and computer software products for controlling biological microarray scanners
US7062092B2 (en) 2000-08-22 2006-06-13 Affymetrix, Inc. System, method, and computer software product for gain adjustment in biological microarray scanner
GB0021286D0 (en) * 2000-08-30 2000-10-18 Gemini Genomics Ab Identification of drug metabolic capacity
US6539102B1 (en) * 2000-09-01 2003-03-25 Large Scale Proteomics Reference database
US6813615B1 (en) 2000-09-06 2004-11-02 Cellomics, Inc. Method and system for interpreting and validating experimental data with automated reasoning
WO2002023308A2 (en) * 2000-09-12 2002-03-21 Viaken Systems, Inc. Techniques for providing and obtaining research and development information technology on remote computing resources
JP2004512514A (en) * 2000-10-23 2004-04-22 ダイアチップ・リミテッド High precision intelligent biochip arrayer with re-spot function
US7117095B2 (en) * 2000-11-21 2006-10-03 Affymetrix, Inc. Methods for selecting nucleic acid probes
US8255791B2 (en) 2000-11-29 2012-08-28 Dov Koren Collaborative, flexible, interactive real-time displays
US7218764B2 (en) 2000-12-04 2007-05-15 Cytokinetics, Inc. Ploidy classification method
US6706867B1 (en) * 2000-12-19 2004-03-16 The United States Of America As Represented By The Department Of Health And Human Services DNA array sequence selection
US20020143768A1 (en) * 2000-12-21 2002-10-03 Berno Anthony Berno Probe array data storage and retrieval
AU2002237879A1 (en) * 2001-01-23 2002-08-06 Gene Logic, Inc. A method and system for predicting the biological activity, including toxicology and toxicity, of substances
US20020183936A1 (en) * 2001-01-24 2002-12-05 Affymetrix, Inc. Method, system, and computer software for providing a genomic web portal
WO2002059271A2 (en) * 2001-01-25 2002-08-01 Gene Logic, Inc. Gene expression profiles in breast tissue
US20030017455A1 (en) * 2001-01-29 2003-01-23 Webb Peter G. Chemical array fabrication with identity map
US6949638B2 (en) * 2001-01-29 2005-09-27 Affymetrix, Inc. Photolithographic method and system for efficient mask usage in manufacturing DNA arrays
US7315784B2 (en) * 2001-02-15 2008-01-01 Siemens Aktiengesellschaft Network for evaluating data obtained in a biochip measurement device
US7016787B2 (en) 2001-02-20 2006-03-21 Cytokinetics, Inc. Characterizing biological stimuli by response curves
US6956961B2 (en) 2001-02-20 2005-10-18 Cytokinetics, Inc. Extracting shape information contained in cell images
WO2002068963A1 (en) * 2001-02-23 2002-09-06 Hitachi, Ltd. Analyzing system
US7110885B2 (en) 2001-03-08 2006-09-19 Dnaprint Genomics, Inc. Efficient methods and apparatus for high-throughput processing of gene sequence data
US20020168651A1 (en) * 2001-03-12 2002-11-14 Affymetrix, Inc. Method and computer software product for determining orientation of sequence clusters
US6804679B2 (en) 2001-03-12 2004-10-12 Affymetrix, Inc. System, method, and user interfaces for managing genomic data
WO2002073504A1 (en) * 2001-03-14 2002-09-19 Gene Logic, Inc. A system and method for retrieving and using gene expression data from multiple sources
JP2002269114A (en) * 2001-03-14 2002-09-20 Kousaku Ookubo Knowledge database, and method for constructing knowledge database
US20040033502A1 (en) * 2001-03-28 2004-02-19 Amanda Williams Gene expression profiles in esophageal tissue
US7251568B2 (en) 2001-04-18 2007-07-31 Wyeth Methods and compositions for regulating bone and cartilage formation
AU2002305193A1 (en) * 2001-04-18 2002-11-05 Wyeth Methods and reagents for regulating bone and cartilage formation
US7155453B2 (en) * 2002-05-22 2006-12-26 Agilent Technologies, Inc. Biotechnology information naming system
US20070015146A1 (en) * 2001-05-22 2007-01-18 Gene Logic, Inc. Molecular nephrotoxicology modeling
WO2002095000A2 (en) * 2001-05-22 2002-11-28 Gene Logic, Inc. Molecular toxicology modeling
US20030009294A1 (en) * 2001-06-07 2003-01-09 Jill Cheng Integrated system for gene expression analysis
WO2002103030A2 (en) * 2001-06-14 2002-12-27 Rigel Pharmaceuticals, Inc. Multidimensional biodata integration and relationship inference
US20040215651A1 (en) * 2001-06-22 2004-10-28 Markowitz Victor M. Platform for management and mining of genomic data
KR100794698B1 (en) * 2001-06-28 2008-01-14 (주)바이오니아 Quality control method for biological chip
AU2002320316A1 (en) * 2001-07-06 2003-01-21 Lipomics Technologies, Inc. Generating, viewing, interpreting, and utilizing a quantitative database of metabolites
US7447594B2 (en) * 2001-07-10 2008-11-04 Ocimum Biosolutions, Inc. Molecular cardiotoxicology modeling
US20040014040A1 (en) * 2001-07-10 2004-01-22 Donna Mendrick Cardiotoxin molecular toxicology modeling
CN1537229A (en) * 2001-07-31 2004-10-13 ���ְ�˹��ʽ���� Gene inspection apparatus and target nucleic acid extraction method using the same
US7251642B1 (en) 2001-08-06 2007-07-31 Gene Logic Inc. Analysis engine and work space manager for use with gene expression data
JP3977038B2 (en) * 2001-08-27 2007-09-19 株式会社半導体エネルギー研究所 Laser irradiation apparatus and laser irradiation method
US20030096248A1 (en) * 2001-09-04 2003-05-22 Vitivity, Inc. Diagnosis and treatment of vascular disease
EP1438420B1 (en) * 2001-09-24 2009-09-16 Lipomics Technologies, Inc. Methods of using quantitative lipid metabolome data
JP2003099624A (en) * 2001-09-25 2003-04-04 Toyo Kohan Co Ltd Dna providing system
US6993173B2 (en) * 2001-10-12 2006-01-31 Duke University Methods for estimating probe cell locations in high-density synthetic DNA microarrays
AU2002334769A1 (en) * 2001-10-12 2003-04-28 Duke University Image analysis of high-density synthetic dna microarrays
US20060141493A1 (en) * 2001-11-09 2006-06-29 Duke University Office Of Science And Technology Atherosclerotic phenotype determinative genes and methods for using the same
US20030224383A1 (en) * 2002-04-23 2003-12-04 Mike West Atherosclerotic phenotype determinative genes and methods for using the same
CN1559026A (en) * 2001-11-12 2004-12-29 �����о�ʵ�������޹�˾ Method and apparatus for protecting information from unauthorised use
KR100474840B1 (en) * 2001-11-15 2005-03-08 삼성전자주식회사 Method and system with directory for providing a genotyping microarray probe design
DE60228995D1 (en) * 2001-12-19 2008-10-30 Affymetrix Inc ARRAY PLATES AND METHOD FOR PRODUCING ARRAY PLATES
US9418204B2 (en) * 2002-01-28 2016-08-16 Samsung Electronics Co., Ltd Bioinformatics system architecture with data and process integration
US20030177143A1 (en) * 2002-01-28 2003-09-18 Steve Gardner Modular bioinformatics platform
US7225183B2 (en) * 2002-01-28 2007-05-29 Ipxl, Inc. Ontology-based information management system and method
CA2474754C (en) * 2002-02-04 2022-03-22 Ingenuity Systems, Inc. Systems for evaluating genomics data
US8793073B2 (en) 2002-02-04 2014-07-29 Ingenuity Systems, Inc. Drug discovery methods
US20030162183A1 (en) * 2002-02-27 2003-08-28 Robert Kincaid Array design system and method
CA2480045C (en) * 2002-03-28 2013-09-24 Medical College Of Ohio Method and compositions for the diagnosis and treatment of non-small cell lung cancer using gene expression profiles
EP1502098B1 (en) * 2002-05-03 2008-09-17 ViaLogy, LLC Method for characterizing microarray output data
US20030220844A1 (en) * 2002-05-24 2003-11-27 Marnellos Georgios E. Method and system for purchasing genetic data
US6763308B2 (en) 2002-05-28 2004-07-13 Sas Institute Inc. Statistical outlier detection for gene expression microarray data
US20030229848A1 (en) * 2002-06-05 2003-12-11 Udo Arend Table filtering in a computer user interface
US7504215B2 (en) 2002-07-12 2009-03-17 Affymetrix, Inc. Nucleic acid labeling methods
US20050112689A1 (en) * 2003-04-04 2005-05-26 Robert Kincaid Systems and methods for statistically analyzing apparent CGH data anomalies and plotting same
US20050216459A1 (en) * 2002-08-08 2005-09-29 Aditya Vailaya Methods and systems, for ontological integration of disparate biological data
US7941542B2 (en) * 2002-09-06 2011-05-10 Oracle International Corporation Methods and apparatus for maintaining application execution over an intermittent network connection
US7512496B2 (en) * 2002-09-25 2009-03-31 Soheil Shams Apparatus, method, and computer program product for determining confidence measures and combined confidence measures for assessing the quality of microarrays
CA2500936C (en) * 2002-09-30 2012-10-30 Nimblegen Systems, Inc. Parallel loading of arrays
CA2500783C (en) * 2002-10-01 2012-07-17 Nimblegen Systems, Inc. Microarrays having multiple oligonucleotides in single array features
US20040259105A1 (en) * 2002-10-03 2004-12-23 Jian-Bing Fan Multiplex nucleic acid analysis using archived or fixed samples
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
JP2006514620A (en) * 2002-11-06 2006-05-11 マウント シナイ スクール オブ メディシン Treatment of amyotrophic lateral sclerosis with Nimesulide
EP2112229A3 (en) 2002-11-25 2009-12-02 Sequenom, Inc. Methods for identifying risk of breast cancer and treatments thereof
WO2004050840A2 (en) * 2002-11-27 2004-06-17 The Government Of The United States As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Integration of gene expression data and non-gene data
KR100506089B1 (en) * 2003-02-05 2005-08-05 삼성전자주식회사 System for designing probe array using heterogeneneous genomic information and method of the same
US7750908B2 (en) * 2003-04-04 2010-07-06 Agilent Technologies, Inc. Focus plus context viewing and manipulation of large collections of graphs
US7825929B2 (en) * 2003-04-04 2010-11-02 Agilent Technologies, Inc. Systems, tools and methods for focus and context viewing of large collections of graphs
WO2004090100A2 (en) * 2003-04-04 2004-10-21 Agilent Technologies, Inc. Visualizing expression data on chromosomal graphic schemes
WO2004096842A2 (en) * 2003-04-28 2004-11-11 Public Health Agency Of Canada Sars virus nucleotide and amino acid sequences and uses thereof
US20040249791A1 (en) * 2003-06-03 2004-12-09 Waters Michael D. Method and system for developing and querying a sequence driven contextual knowledge base
EP3305919A1 (en) 2003-06-10 2018-04-11 The Trustees of Boston University Detection methods for disorders of the lung
US20050064462A1 (en) * 2003-06-17 2005-03-24 Bernd Stein Methods, compositions, and kits for predicting the effect of compounds on hot flash symptoms
US7246012B2 (en) 2003-07-18 2007-07-17 Cytokinetics, Inc. Characterizing biological stimuli by response curves
US20050014217A1 (en) 2003-07-18 2005-01-20 Cytokinetics, Inc. Predicting hepatotoxicity using cell based assays
US7235353B2 (en) 2003-07-18 2007-06-26 Cytokinetics, Inc. Predicting hepatotoxicity using cell based assays
US20050026306A1 (en) * 2003-07-31 2005-02-03 Robert Kincaid Method and system for generating virtual-microarrays
US7353116B2 (en) * 2003-07-31 2008-04-01 Agilent Technologies, Inc. Chemical array with test dependent signal reading or processing
US20050026154A1 (en) * 2003-07-31 2005-02-03 Laurakay Bruhn Masking chemical arrays
US7475087B1 (en) 2003-08-29 2009-01-06 The United States Of America As Represented By The Secretary Of Agriculture Computer display tool for visualizing relationships between and among data
US20050049796A1 (en) * 2003-09-03 2005-03-03 Webb Peter G. Methods for encoding non-biological information on microarrays
US20050048506A1 (en) * 2003-09-03 2005-03-03 Fredrick Joseph P. Methods for encoding non-biological information on microarrays
US9394565B2 (en) 2003-09-05 2016-07-19 Agena Bioscience, Inc. Allele-specific sequence variation analysis
JP2007512838A (en) 2003-12-01 2007-05-24 インヴィトロジェン コーポレーション Nucleic acid molecules containing recombination sites and methods of use thereof
CA2497324A1 (en) 2004-02-17 2005-08-17 Affymetrix, Inc. Methods for fragmenting and labelling dna
US7660709B2 (en) * 2004-03-18 2010-02-09 Van Andel Research Institute Bioinformatics research and analysis system and methods associated therewith
CA2561381C (en) 2004-03-26 2015-05-12 Sequenom, Inc. Base specific cleavage of methylation-specific amplification products in combination with mass analysis
KR100632973B1 (en) * 2004-04-29 2006-10-12 주식회사 메딘텔 Circular matching system and method for circular matching
US20060003335A1 (en) * 2004-06-30 2006-01-05 Crispino John D Methods for diagnosing acute megakaryoblastic leukemia
US7323318B2 (en) 2004-07-15 2008-01-29 Cytokinetics, Inc. Assay for distinguishing live and dead cells
EP1773860A4 (en) * 2004-07-22 2009-05-06 Sequenom Inc Methods for identifying risk of type ii diabetes and treatments thereof
US8603824B2 (en) 2004-07-26 2013-12-10 Pfenex, Inc. Process for improved protein expression by strain engineering
WO2006130165A2 (en) * 2004-09-02 2006-12-07 Vialogy Corp. Detecting events of interest using quantum resonance interferometry
US20060073506A1 (en) 2004-09-17 2006-04-06 Affymetrix, Inc. Methods for identifying biological samples
US20060073511A1 (en) 2004-10-05 2006-04-06 Affymetrix, Inc. Methods for amplifying and analyzing nucleic acids
US20060083609A1 (en) * 2004-10-14 2006-04-20 Augspurger Murray D Fluid cooled marine turbine housing
US7682782B2 (en) 2004-10-29 2010-03-23 Affymetrix, Inc. System, method, and product for multiple wavelength detection using single source excitation
EP1652580A1 (en) 2004-10-29 2006-05-03 Affymetrix, Inc. High throughput microarray, package assembly and methods of manufacturing arrays
US20090068650A1 (en) * 2005-02-11 2009-03-12 Southern Illinois University Metabolic Primers for the Detection of (Per) Chlorate-Reducing Bacteria and Methods of Use Thereof
US20060211004A1 (en) 2005-02-15 2006-09-21 Ilsley Diane D Methods and compositions for determining non-specific cytotoxicity of a transfection agent
US8178291B2 (en) 2005-02-18 2012-05-15 Monogram Biosciences, Inc. Methods and compositions for determining hypersusceptibility of HIV-1 to non-nucleoside reverse transcriptase inhibitors
US20090203547A1 (en) * 2005-02-18 2009-08-13 Albert Banes Gene and Cognate Protein Profiles and Methods to Determine Connective Tissue Markers in Normal and Pathologic Conditions
WO2006089046A2 (en) 2005-02-18 2006-08-24 Monogram Biosciences, Inc. Methods and compositions for determining anti-hiv drug susceptibility and replication capacity of hiv
US20070118295A1 (en) * 2005-03-02 2007-05-24 Al-Murrani Samer Waleed Khedhe Methods and Systems for Designing Animal Food Compositions
US20060286569A1 (en) * 2005-03-10 2006-12-21 Bar-Or Yuval A Method, apparatus, and system for authentication using labels containing nucleotide sequences
EP2604703B1 (en) 2005-03-14 2017-02-01 The Board of Trustees of the Leland Stanford Junior University Methods for evaluating graft survival in a solid organ transplant recipient
EP2360279A1 (en) 2005-04-14 2011-08-24 Trustees Of Boston University Diagnostic for lung disorders using class prediction
US20070026426A1 (en) * 2005-04-26 2007-02-01 Applera Corporation System for genetic surveillance and analysis
EP2458018A3 (en) 2005-05-27 2012-07-25 Monogram BioSciences, Inc. Methods and compositions for determining resistance of HIV-1 to protease inhibitors
US8071284B2 (en) * 2005-06-06 2011-12-06 Monogram Biosciences, Inc. Methods and compositions for determining altered susceptibility of HIV-1 to anti-HIV drugs
WO2006133266A2 (en) 2005-06-06 2006-12-14 Monogram Biosciences, Inc. Methods for determining resistance or susceptibility to hiv entry inhibitors
US8159959B2 (en) * 2005-11-07 2012-04-17 Vudu, Inc. Graphic user interface for playing video data
US7634363B2 (en) 2005-12-07 2009-12-15 Affymetrix, Inc. Methods for high throughput genotyping
EP1969506A1 (en) * 2005-12-13 2008-09-17 Erasmus University Medical Center Rotterdam Genetic brain tumor markers
US7646450B2 (en) * 2005-12-29 2010-01-12 Lg Display Co., Ltd. Light emitting diode array, method of manufacturing the same, backlight assembly having the same, and LCD having the same
US20070198729A1 (en) * 2006-02-07 2007-08-23 Yechuri Sitaramarao S SQL network gadget
JP2009529329A (en) 2006-03-09 2009-08-20 トラスティーズ オブ ボストン ユニバーシティ Methods for diagnosis and prognosis for lung diseases using gene expression profiles of nasal epithelial cells
US20100285973A1 (en) * 2006-05-30 2010-11-11 Synergenz Bioscience Limited of Sea Meadow House Methods and compositions for assessment of pulmonary function and disorders
EP2602321B1 (en) 2006-05-31 2017-08-23 Sequenom, Inc. Methods and compositions for the extraction and amplification of nucleic acid from a sample
US8153369B2 (en) 2006-06-05 2012-04-10 Cancer Care Ontario Assessment of risk for colorectal cancer
US20080033985A1 (en) * 2006-06-09 2008-02-07 Gulfstream Bioinformatics Corporation Biomedical Information Modeling
US7700756B2 (en) * 2006-07-27 2010-04-20 Southern Illinois University Metabolic primers for the detection of perchlorate-reducing bacteria and methods of use thereof
CA2658991A1 (en) * 2006-07-28 2008-01-31 Ingenuity Systems, Inc. Genomics based targeted advertising
AU2007284651B2 (en) 2006-08-09 2014-03-20 Institute For Systems Biology Organ-specific proteins and methods of their use
EP2074224A4 (en) * 2006-10-17 2010-07-21 Synergenz Bioscience Ltd Methods and compositions for assessment of pulmonary function and disorders
US9845494B2 (en) 2006-10-18 2017-12-19 Affymetrix, Inc. Enzymatic methods for genotyping on arrays
WO2008066655A2 (en) 2006-11-02 2008-06-05 Yale University Assessment of oocyte competence
NZ551157A (en) * 2006-11-08 2008-06-30 Rebecca Lee Roberts Method of identifying individuals at risk of thiopurine drug resistance and intolerance - GMPS
US8293684B2 (en) * 2006-11-29 2012-10-23 Exiqon Locked nucleic acid reagents for labelling nucleic acids
US7902345B2 (en) 2006-12-05 2011-03-08 Sequenom, Inc. Detection and quantification of biomolecules using mass spectrometry
EP2129795A4 (en) * 2006-12-19 2010-10-20 Synergenz Bioscience Ltd Methods and compositions for the assessment of cardiovascular function and disorders
EP2107911A4 (en) 2007-01-30 2010-09-22 Pharmacyclics Inc Methods for determining cancer resistance to histone deacetylase inhibitors
WO2008098142A2 (en) 2007-02-08 2008-08-14 Sequenom, Inc. Nucleic acid-based tests for rhd typing, gender determination and nucleic acid quantification
US9581595B2 (en) 2007-02-26 2017-02-28 Laboratory Corporation Of America Holdings Compositions and methods for determining whether a subject would benefit from co-receptor inhibitor therapy
CA2679954A1 (en) 2007-03-05 2008-09-12 Cancer Care Ontario Assessment of risk for colorectal cancer
US8652780B2 (en) 2007-03-26 2014-02-18 Sequenom, Inc. Restriction endonuclease enhanced polymorphic sequence detection
US9580719B2 (en) * 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
EP2142651B1 (en) 2007-04-27 2013-05-22 Pfenex Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
US8200440B2 (en) 2007-05-18 2012-06-12 Affymetrix, Inc. System, method, and computer software product for genotype determination using probe array data
WO2009032781A2 (en) 2007-08-29 2009-03-12 Sequenom, Inc. Methods and compositions for universal size-specific polymerase chain reaction
WO2009039190A1 (en) * 2007-09-17 2009-03-26 Gene Express, Inc. Cancer risk biomarker
NZ600235A (en) 2008-01-25 2013-11-29 Theranostics Lab Methods and compositions for the assessment of drug response
WO2009113779A2 (en) 2008-03-11 2009-09-17 국립암센터 Method for measuring chromosome, gene or specific nucleotide sequence copy numbers using snp array
EP2271772B1 (en) 2008-03-11 2014-07-16 Sequenom, Inc. Nucleic acid-based tests for prenatal gender determination
US8206926B2 (en) 2008-03-26 2012-06-26 Sequenom, Inc. Restriction endonuclease enhanced polymorphic sequence detection
JP2011525106A (en) * 2008-06-04 2011-09-15 ジ・アリゾナ・ボード・オブ・リージェンツ・オン・ビハーフ・オブ・ザ・ユニバーシティ・オブ・アリゾナ Markers for diffuse B large cell lymphoma and methods of use thereof
US20110201519A1 (en) 2008-08-18 2011-08-18 Sarwal Minnie M Methods and Compositions for Determining a Graft Tolerant Phenotype in a Subject
US8962247B2 (en) * 2008-09-16 2015-02-24 Sequenom, Inc. Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
US8476013B2 (en) 2008-09-16 2013-07-02 Sequenom, Inc. Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
EP2352503B1 (en) 2008-11-06 2017-07-19 University of Miami Role of soluble upar in the pathogenesis of proteinuric kidney disease
US8039794B2 (en) * 2008-12-16 2011-10-18 Quest Diagnostics Investments Incorporated Mass spectrometry assay for thiopurine-S-methyl transferase activity and products generated thereby
KR101025848B1 (en) * 2008-12-30 2011-03-30 삼성전자주식회사 The method and apparatus for integrating and managing personal genome
EP4328589A2 (en) 2009-01-07 2024-02-28 Myriad Genetics, Inc. Cancer biomarkers
CN102333891A (en) * 2009-01-20 2012-01-25 利兰·斯坦福青年大学托管委员会 Single cell gene expression for diagnosis, prognosis and identification of drug targets
JP2012517238A (en) 2009-02-11 2012-08-02 カリス エムピーアイ インコーポレイテッド Molecular profiling of tumors
US8832581B2 (en) * 2009-03-05 2014-09-09 Ming Zhang Gene expression browser for web-based search and visualization of characteristics of gene expression
CN102428191A (en) * 2009-03-18 2012-04-25 塞昆纳姆股份有限公司 Use Of Thermostable Endonucleases For Generating Reporter Molecules
EP2414545B1 (en) 2009-04-03 2017-01-11 Sequenom, Inc. Nucleic acid preparation compositions and methods
WO2011056688A2 (en) 2009-10-27 2011-05-12 Caris Life Sciences, Inc. Molecular profiling for personalized medicine
US20110201008A1 (en) * 2009-12-01 2011-08-18 University Of Miami Assays, methods and kits for measuring response to therapy and predicting clinical outcome in patients with b-cell lymphoma
WO2011068829A1 (en) 2009-12-02 2011-06-09 The Board Of Trustees Of The Leland Stanford Junior University Biomarkers for determining an allograft tolerant phenotype
US8501122B2 (en) 2009-12-08 2013-08-06 Affymetrix, Inc. Manufacturing and processing polymer arrays
US8835358B2 (en) 2009-12-15 2014-09-16 Cellular Research, Inc. Digital counting of individual molecules by stochastic attachment of diverse labels
ES2577017T3 (en) 2009-12-22 2016-07-12 Sequenom, Inc. Procedures and kits to identify aneuploidy
US9798855B2 (en) 2010-01-07 2017-10-24 Affymetrix, Inc. Differential filtering of genetic data
WO2011091435A2 (en) 2010-01-25 2011-07-28 Mount Sinai School Of Medicine Methods of treating liver disease
ES2798114T3 (en) 2010-03-25 2020-12-09 Univ Leland Stanford Junior Protein and gene biomarkers for organ transplant rejection
US8980253B2 (en) 2010-04-26 2015-03-17 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-tRNA synthetase
WO2011139799A2 (en) 2010-04-27 2011-11-10 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl trna synthetases
US8993723B2 (en) 2010-04-28 2015-03-31 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl-tRNA synthetases
EP2563912B1 (en) 2010-04-29 2018-09-05 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl trna synthetases
EP2563383B1 (en) 2010-04-29 2017-03-01 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases
CN103096925A (en) 2010-05-03 2013-05-08 Atyr医药公司 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-tRNA synthetases
WO2011140135A2 (en) 2010-05-03 2011-11-10 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases
WO2011140132A2 (en) 2010-05-03 2011-11-10 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-trna synthetases
CN102985103A (en) 2010-05-04 2013-03-20 Atyr医药公司 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-tRNA synthetase complex
WO2011143482A2 (en) 2010-05-14 2011-11-17 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases
AU2011258106B2 (en) 2010-05-27 2017-02-23 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-tRNA synthetases
AU2011261486B2 (en) 2010-06-01 2017-02-23 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-tRNA synthetases
EP2591126B1 (en) 2010-07-07 2020-12-30 Myriad Genetics, Inc. Gene signatures for cancer prognosis
AU2011289831C1 (en) 2010-07-12 2017-06-15 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
EP2608801B1 (en) 2010-08-25 2019-08-21 aTyr Pharma, Inc. INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF TYROSYL-tRNA SYNTHETASES
US20120075325A1 (en) * 2010-09-09 2012-03-29 Abbott Laboratories Systems and methods for displaying molecular probes and chromosomes
KR20130115250A (en) 2010-09-15 2013-10-21 알막 다이아그노스틱스 리미티드 Molecular diagnostic test for cancer
US8460872B2 (en) 2011-04-29 2013-06-11 Sequenom, Inc. Quantification of a minority nucleic acid species
CA2862499C (en) 2012-01-24 2020-10-27 Cd Diagnostics, Inc. System for detecting infection in synovial fluid
CN104334196B (en) 2012-02-16 2018-04-10 Atyr 医药公司 For treating the Histidyl-tRNA-synthetase of autoimmune disease and inflammatory disease
ES2776673T3 (en) 2012-02-27 2020-07-31 Univ North Carolina Chapel Hill Methods and uses for molecular tags
EP3321378B1 (en) 2012-02-27 2021-11-10 Becton, Dickinson and Company Compositions for molecular counting
EP2820129A1 (en) 2012-03-02 2015-01-07 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US9920361B2 (en) 2012-05-21 2018-03-20 Sequenom, Inc. Methods and compositions for analyzing nucleic acid
AU2013290102B2 (en) 2012-07-13 2018-11-15 Sequenom, Inc. Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
US8766754B2 (en) 2012-07-18 2014-07-01 The Regents Of The University Of California Concave nanomagnets with widely tunable anisotropy
EP4190918A1 (en) 2012-11-16 2023-06-07 Myriad Genetics, Inc. Gene signatures for cancer prognosis
BR112015012239B1 (en) 2012-11-27 2022-07-19 Pontificia Universidad Católica De Chile IN VITRO METHOD OF DIAGNOSIS OF THYROID CANCER
US9896728B2 (en) 2013-01-29 2018-02-20 Arcticrx Ltd. Method for determining a therapeutic approach for the treatment of age-related macular degeneration (AMD)
EP2971100A1 (en) 2013-03-13 2016-01-20 Sequenom, Inc. Primers for dna methylation analysis
WO2014151026A1 (en) 2013-03-15 2014-09-25 Myriad Genetics, Inc. Genes and gene signatures for diagnosis and treatment of melanoma
US10535420B2 (en) 2013-03-15 2020-01-14 Affymetrix, Inc. Systems and methods for probe design to detect the presence of simple and complex indels
KR101520615B1 (en) 2013-03-20 2015-05-18 서울대학교산학협력단 Markers for diagnosis of liver cancer
US10390724B2 (en) 2013-06-26 2019-08-27 The Penn State Research Foundation Three-dimensional bio-medical probe sensing and contacting structures with addressibility and tunability
JP6463359B2 (en) 2013-08-12 2019-01-30 ジェネンテック, インコーポレイテッド Compositions and methods for treating complement related conditions
KR101527283B1 (en) 2013-08-13 2015-06-10 서울대학교산학협력단 Method for screening cancer marker based on de-glycosylation of glycoproteins and marker for HCC
EP3102230B1 (en) 2014-02-08 2021-04-28 F. Hoffmann-La Roche AG Methods of treating alzheimer's disease
WO2015138774A1 (en) 2014-03-13 2015-09-17 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
UA123387C2 (en) 2014-04-22 2021-03-31 Інвайролоджикс, Інк. Compositions and methods for enhancing and/or predicting dna amplification
WO2015175692A1 (en) 2014-05-13 2015-11-19 Myriad Genetics, Inc. Gene signatures for cancer prognosis
EP3164508B1 (en) 2014-07-02 2023-06-07 Myriad myPath, LLC Genes and gene signatures for diagnosis and treatment of melanoma
US11053550B2 (en) 2014-10-14 2021-07-06 The University Of North Carolina At Chapel Hill Gene-expression based subtyping of pancreatic ductal adenocarcinoma
EP4141128A1 (en) 2014-10-20 2023-03-01 Envirologix Inc. Compositions and methods for detecting an rna virus
JP6415712B2 (en) 2014-10-24 2018-10-31 コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. Assessment of TGF-β cell signaling pathway activity using mathematical modeling of target gene expression
ES2857953T3 (en) 2014-10-24 2021-09-29 Koninklijke Philips Nv Medical prognosis and prediction of response to treatment using the activities of multiple cell signaling pathways
JP7065610B6 (en) 2014-10-24 2022-06-06 コーニンクレッカ フィリップス エヌ ヴェ Medical prognosis and prediction of therapeutic response using multiple cellular signaling pathway activities
RU2755495C2 (en) 2015-01-30 2021-09-16 Инвайролоджикс Инк. Substrate molecule
WO2016126253A1 (en) 2015-02-05 2016-08-11 The Penn State Research Foundation Nano-pore arrays for bio-medical, environmental, and industrial sorting, filtering, monitoring, or dispensing
JP6722173B2 (en) * 2015-04-13 2020-07-15 国立研究開発法人産業技術総合研究所 Experimental data recording device, computer program, experimental data recording method, experimental data display device, and experimental data display method
GB201512869D0 (en) 2015-07-21 2015-09-02 Almac Diagnostics Ltd Gene signature for minute therapies
EP3331572A4 (en) 2015-08-04 2019-05-01 CD Diagnostics, Inc. Methods for detecting adverse local tissue reaction (altr) necrosis
KR102618536B1 (en) * 2015-08-12 2023-12-27 삼성전자주식회사 Method and device for mutation prioritization for personalized therapy of one or more patients
US10720227B2 (en) * 2015-08-12 2020-07-21 Samsung Electronics Co., Ltd. Method and device for mutation prioritization for personalized therapy
JP7028763B2 (en) 2015-08-14 2022-03-02 コーニンクレッカ フィリップス エヌ ヴェ Assessment of NFkB cell signaling pathway activity using mathematical modeling of target gene expression
WO2017070096A1 (en) 2015-10-18 2017-04-27 Affymetrix, Inc. Multiallelic genotyping of single nucleotide polymorphisms and indels
CA3005119A1 (en) 2015-11-19 2017-05-26 Myriad Genetics, Inc. Signatures for predicting cancer immune therapy response
US9836444B2 (en) * 2015-12-10 2017-12-05 International Business Machines Corporation Spread cell value visualization
WO2017120456A1 (en) 2016-01-06 2017-07-13 Myriad Genetics, Inc. Genes and gene signatures for diagnosis and treatment of melanoma
CN109073654A (en) 2016-04-20 2018-12-21 苏州爱尔迪思生物科技有限公司 For predicting the method and composition of premature labor
WO2017193062A1 (en) 2016-05-06 2017-11-09 Myriad Genetics, Inc. Gene signatures for renal cancer prognosis
CN109196362A (en) 2016-05-17 2019-01-11 苏州爱尔迪思生物科技有限公司 For providing the method and composition of preeclampsia assessment
CN106066948B (en) * 2016-06-07 2018-09-28 北京大学 A kind of gene expression amount shows method and device
CN109983348A (en) * 2016-09-27 2019-07-05 Bae系统信息和电子系统集成有限公司 Realize the technology of portable frequency spectrum analyzer
US20180165414A1 (en) * 2016-12-14 2018-06-14 FlowJo, LLC Applied Computer Technology for Management, Synthesis, Visualization, and Exploration of Parameters in Large Multi-Parameter Data Sets
KR102116178B1 (en) 2017-05-10 2020-05-27 서울대학교산학협력단 Biomarker for monitoring or detecting early onset of liver cancer from patient having high risk of liver cancer and its use
US11573182B2 (en) 2017-05-25 2023-02-07 FlowJo, LLC Visualization, comparative analysis, and automated difference detection for large multi-parameter data sets
EP3461915A1 (en) 2017-10-02 2019-04-03 Koninklijke Philips N.V. Assessment of jak-stat1/2 cellular signaling pathway activity using mathematical modelling of target gene expression
EP3502279A1 (en) 2017-12-20 2019-06-26 Koninklijke Philips N.V. Assessment of mapk-ap 1 cellular signaling pathway activity using mathematical modelling of target gene expression
US20190211098A1 (en) 2017-12-22 2019-07-11 Genentech, Inc. Use of pilra binding agents for treatment of a disease
GB2574582A (en) * 2018-05-28 2019-12-18 Rainer Gabriel Schweiger Martin Method for simulating a technical device
WO2019246160A2 (en) 2018-06-18 2019-12-26 Igenomix, S.L. Methods, compositions, and kits for assessing endometrial transformation
EP3864165A4 (en) 2018-10-09 2022-08-03 Genecentric Therapeutics, Inc. Detecting cancer cell of origin
CA3121170A1 (en) 2018-11-30 2020-06-04 Caris Mpi, Inc. Next-generation molecular profiling
WO2020212580A1 (en) 2019-04-17 2020-10-22 Igenomix, S.L. Improved methods for the early diagnosis of uterine leiomyomas and leiomyosarcomas
AU2020397802A1 (en) 2019-12-02 2022-06-16 Caris Mpi, Inc. Pan-cancer platinum response predictor
WO2023178295A1 (en) 2022-03-18 2023-09-21 Ludwig Institute For Cancer Research Ltd Methods and systems for analyzing chromatins

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5571639A (en) * 1994-05-24 1996-11-05 Affymax Technologies N.V. Computer-aided engineering system for design of sequence arrays and lithographic masks

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
NO870613L (en) 1986-03-05 1987-09-07 Molecular Diagnostics Inc DETECTION OF MICROORGANISMS IN A SAMPLE CONTAINING NUCLEIC ACID.
US4740611A (en) * 1986-10-30 1988-04-26 The Standard Oil Company N,N'-disubstituted ureas
US4705864A (en) * 1986-11-10 1987-11-10 The Standard Oil Company Aryl oxime derivatives of hydantoins
EP0307476A4 (en) 1986-12-20 1990-12-12 Kukita, Takeshi Bilirubin antigen, monoclonal antibody therefor, process for their preparation, and their use
US5525464A (en) 1987-04-01 1996-06-11 Hyseq, Inc. Method of sequencing by hybridization of oligonucleotide probes
US5202231A (en) 1987-04-01 1993-04-13 Drmanac Radoje T Method of sequencing of genomes by hybridization of oligonucleotide probes
US5700637A (en) 1988-05-03 1997-12-23 Isis Innovation Limited Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays
EP0451141B1 (en) 1988-05-20 1998-11-18 F. Hoffmann-La Roche Ag Immobilized sequence-specific probes
US5206137A (en) * 1988-09-08 1993-04-27 Lifecodes Corporation Compositions and methods useful for genetic analysis
US6203977B1 (en) * 1988-11-15 2001-03-20 Yale University Delineation of individual human chromosomes in metaphase and interphase cells by in situ suppression hybridization
JPH02299598A (en) 1989-04-14 1990-12-11 Ro Inst For Molecular Genetics & Geneteic Res Determination by means of hybridization, together with oligonucleotide probe of all or part of extremely short sequence in sample of nucleic acid connecting with separate particle of microscopic size
US6040138A (en) * 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5800992A (en) * 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US5925525A (en) * 1989-06-07 1999-07-20 Affymetrix, Inc. Method of identifying nucleotide differences
US5871928A (en) * 1989-06-07 1999-02-16 Fodor; Stephen P. A. Methods for nucleic acid analysis
EP0834576B1 (en) 1990-12-06 2002-01-16 Affymetrix, Inc. (a Delaware Corporation) Detection of nucleic acid sequences
ES2155822T3 (en) 1990-12-06 2001-06-01 Affymetrix Inc COMPOUNDS AND ITS USE IN A BINARY SYNTHESIS STRATEGY.
GR1000797B (en) 1991-06-10 1993-01-25 Emmanouil E Petromanolakis Wave-making energy absorber during vessel s propulsion
AU663101B2 (en) * 1991-08-13 1995-09-28 Wisconsin Milk Marketing Board DNA sequence encoding bovine alpha-lactalbumin and methods of use
US5846717A (en) * 1996-01-24 1998-12-08 Third Wave Technologies, Inc. Detection of nucleic acid sequences by invader-directed cleavage
ATE198358T1 (en) 1992-04-27 2001-01-15 Dartmouth College DETECTION OF GENE SEQUENCES IN BIOLOGICAL LIQUIDS
US6251920B1 (en) * 1993-05-13 2001-06-26 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6395494B1 (en) * 1993-05-13 2002-05-28 Neorx Corporation Method to determine TGF-β
US5524070A (en) * 1992-10-07 1996-06-04 The Research Foundation Of State University Of New York Local adaptive contrast enhancement
US5632282A (en) * 1993-07-20 1997-05-27 Hay; S. Hutson Ocular disease detection apparatus
JPH09507121A (en) 1993-10-26 1997-07-22 アフィマックス テクノロジーズ ナームロゼ ベノートスハップ Nucleic acid probe array on biological chip
JP3488465B2 (en) 1993-10-28 2004-01-19 ヒューストン・アドバンスド・リサーチ・センター Microfabricated flow-through porosity device for separately detecting binding reactions
US6096503A (en) * 1993-11-12 2000-08-01 The Scripps Research Institute Method for simultaneous identification of differentially expresses mRNAs and measurement of relative concentrations
US6339767B1 (en) * 1997-06-02 2002-01-15 Aurigin Systems, Inc. Using hyperbolic trees to visualize data generated by patent-centric and group-oriented data processing
EP0667586A3 (en) * 1994-02-14 1996-08-28 Digital Equipment Corp Database generator.
US5560005A (en) * 1994-02-25 1996-09-24 Actamed Corp. Methods and systems for object-based relational distributed databases
US5570291A (en) * 1994-08-24 1996-10-29 Wallace Computer Services, Inc. Custom product estimating and order processing system
WO1997027317A1 (en) 1996-01-23 1997-07-31 Affymetrix, Inc. Nucleic acid analysis techniques
US6600996B2 (en) 1994-10-21 2003-07-29 Affymetrix, Inc. Computer-aided techniques for analyzing biological sequences
US5795716A (en) * 1994-10-21 1998-08-18 Chee; Mark S. Computer-aided visualization and analysis system for sequence evaluation
JPH11501741A (en) 1995-01-27 1999-02-09 インサイト ファーマシューティカルズ インク. Computer system for storing and analyzing microbiological data
US5961923A (en) * 1995-04-25 1999-10-05 Irori Matrices with memories and uses thereof
US5744575A (en) * 1995-06-06 1998-04-28 Ube Industries, Ltd. Aromatic polyimide and gas separation
US5707806A (en) * 1995-06-07 1998-01-13 Genzyme Corporation Direct sequence identification of mutations by cleavage- and ligation-associated mutation-specific sequencing
US5777888A (en) 1995-08-09 1998-07-07 Regents Of The University Of California Systems for generating and analyzing stimulus-response output signal matrices
US5871697A (en) 1995-10-24 1999-02-16 Curagen Corporation Method and apparatus for identifying, classifying, or quantifying DNA sequences in a sample without sequencing
GB9522615D0 (en) 1995-11-03 1996-01-03 Pharmacia Spa 4-Phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity
US5778200A (en) 1995-11-21 1998-07-07 Advanced Micro Devices, Inc. Bus arbiter including aging factor counters to dynamically vary arbitration priority
US6228575B1 (en) 1996-02-08 2001-05-08 Affymetrix, Inc. Chip-based species identification and phenotypic characterization of microorganisms
US6108635A (en) * 1996-05-22 2000-08-22 Interleukin Genetics, Inc. Integrated disease information system
US5989835A (en) * 1997-02-27 1999-11-23 Cellomics, Inc. System for cell-based screening
IL129498A0 (en) * 1996-11-04 2000-02-29 Dimensional Pharm Inc System method and computer program product for identifying chemical compounds having desired properties
US5968784A (en) * 1997-01-15 1999-10-19 Chugai Pharmaceutical Co., Ltd. Method for analyzing quantitative expression of genes
US6205447B1 (en) * 1997-06-30 2001-03-20 International Business Machines Corporation Relational database management of multi-dimensional data
WO1999005323A1 (en) * 1997-07-25 1999-02-04 Affymetrix, Inc. Gene expression and evaluation system
US6032151A (en) * 1997-11-17 2000-02-29 Sun Microsystems, Inc. Database system employing polymorphic entry and entry matching
US6025194A (en) * 1997-11-19 2000-02-15 Geron Corporation Nucleic acid sequence of senescence asssociated gene
US5991766A (en) * 1997-12-02 1999-11-23 Electronic Data Systems Corporation Method and system for managing redundant objects in a distributed object system
US20030036855A1 (en) * 1998-03-16 2003-02-20 Praelux Incorporated, A Corporation Of New Jersey Method and apparatus for screening chemical compounds
US6324533B1 (en) * 1998-05-29 2001-11-27 International Business Machines Corporation Integrated database and data-mining system
US6331396B1 (en) * 1998-09-23 2001-12-18 The Cleveland Clinic Foundation Arrays for identifying agents which mimic or inhibit the activity of interferons
US6140054A (en) * 1998-09-30 2000-10-31 University Of Utah Research Foundation Multiplex genotyping using fluorescent hybridization probes
US6251601B1 (en) * 1999-02-02 2001-06-26 Vysis, Inc. Simultaneous measurement of gene expression and genomic abnormalities using nucleic acid microarrays
US6284465B1 (en) * 1999-04-15 2001-09-04 Agilent Technologies, Inc. Apparatus, systems and method for locating nucleic acids bound to surfaces
US6338071B1 (en) * 1999-08-18 2002-01-08 Affymetrix, Inc. Method and system for providing a contract management system using an action-item table
US6754666B1 (en) * 1999-08-19 2004-06-22 A2I, Inc. Efficient storage and access in a database management system
WO2001014328A2 (en) * 1999-08-20 2001-03-01 Merck & Co., Inc. Substituted ureas as cell adhesion inhibitors
US7072896B2 (en) * 2000-02-16 2006-07-04 Verizon Laboratories Inc. System and method for automatic loading of an XML document defined by a document-type definition into a relational database including the generation of a relational schema therefor
US6569615B1 (en) * 2000-04-10 2003-05-27 The United States Of America As Represented By The Department Of Veteran's Affairs Composition and methods for tissue preservation
US20020062258A1 (en) * 2000-05-18 2002-05-23 Bailey Steven C. Computer-implemented procurement of items using parametric searching
US7731904B2 (en) * 2000-09-19 2010-06-08 Canon Kabushiki Kaisha Method for making probe support and apparatus used for the method
US6872533B2 (en) * 2001-07-27 2005-03-29 The Regents Of The University Of California STK15 (STK6) gene polymorphism and methods of determining cancer risk
US20030126139A1 (en) * 2001-12-28 2003-07-03 Lee Timothy A. System and method for loading commercial web sites

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5571639A (en) * 1994-05-24 1996-11-05 Affymax Technologies N.V. Computer-aided engineering system for design of sequence arrays and lithographic masks
US5593839A (en) * 1994-05-24 1997-01-14 Affymetrix, Inc. Computer-aided engineering system for design of sequence arrays and lithographic masks

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001013105A1 (en) * 1999-07-30 2001-02-22 Agy Therapeutics, Inc. Techniques for facilitating identification of candidate genes
US6470277B1 (en) 1999-07-30 2002-10-22 Agy Therapeutics, Inc. Techniques for facilitating identification of candidate genes
EP1978098A2 (en) 1999-12-10 2008-10-08 Invitrogen Corporation Use of multiple recombination sites with unique specificity in recombinational cloning
EP2210948A2 (en) 1999-12-10 2010-07-28 Life Technologies Corporation Use of multiple recombination sites with unique specificity in recombinational cloning
WO2001080155A2 (en) * 2000-04-18 2001-10-25 Combimatrix Corporation Automated system and process for custom-designed biological array design and analysis
WO2001080155A3 (en) * 2000-04-18 2003-03-20 Combimatrix Corp Automated system and process for custom-designed biological array design and analysis
AU784944B2 (en) * 2000-04-18 2006-08-03 Combimatrix Corporation Automated system and process for custom-designed biological array design and analysis
JP2002297617A (en) * 2001-03-29 2002-10-11 Hitachi Software Eng Co Ltd Method for displaying correlation between biopolymer and probe
US6919201B2 (en) * 2002-12-11 2005-07-19 Yokogawa Electric Corporation Biochip measuring method and measuring equipment

Also Published As

Publication number Publication date
JP2001511529A (en) 2001-08-14
EP1009861A4 (en) 2002-10-16
US20020062319A1 (en) 2002-05-23
US6484183B1 (en) 2002-11-19
DE69823206T2 (en) 2004-08-19
JP2005100389A (en) 2005-04-14
EP0998697A1 (en) 2000-05-10
US20030125882A1 (en) 2003-07-03
EP1007737A4 (en) 2002-07-03
US6188783B1 (en) 2001-02-13
US20050164270A1 (en) 2005-07-28
EP1007737A1 (en) 2000-06-14
WO1999005324A1 (en) 1999-02-04
US6229911B1 (en) 2001-05-08
US20020012456A1 (en) 2002-01-31
EP1002264A2 (en) 2000-05-24
JP2001511550A (en) 2001-08-14
JP3776728B2 (en) 2006-05-17
WO1999005591A2 (en) 1999-02-04
JP2001511546A (en) 2001-08-14
US20050157915A1 (en) 2005-07-21
EP1009861A1 (en) 2000-06-21
JP2005353057A (en) 2005-12-22
US6882742B2 (en) 2005-04-19
ATE264523T1 (en) 2004-04-15
WO1999005591A3 (en) 1999-05-20
JP2001515234A (en) 2001-09-18
US6567540B2 (en) 2003-05-20
US6532462B2 (en) 2003-03-11
WO1999005323A1 (en) 1999-02-04
US7215804B2 (en) 2007-05-08
EP1002264A4 (en) 2002-07-03
EP0998697A4 (en) 2002-07-24
EP1002264B1 (en) 2004-04-14
US6308170B1 (en) 2001-10-23
US20030074363A1 (en) 2003-04-17
DE69823206D1 (en) 2004-05-19

Similar Documents

Publication Publication Date Title
US6826296B2 (en) Method and system for providing a probe array chip design database
US6188783B1 (en) Method and system for providing a probe array chip design database
US6687692B1 (en) Method and apparatus for providing an expression data mining database
US6223186B1 (en) System and method for a precompiled database for biomolecular sequence information
US20030171876A1 (en) System and method for managing gene expression data
US20020183936A1 (en) Method, system, and computer software for providing a genomic web portal
US20040012633A1 (en) System, method, and computer program product for dynamic display, and analysis of biological sequence data
JP2011238252A (en) Artificial intelligence system for gene analysis
US20030028501A1 (en) Computer based method for providing a laboratory information management system
US20060271513A1 (en) Method and apparatus for providing an expression data mining database
JP2004535612A (en) Gene expression data management system and method
US20060212229A1 (en) Method and system for providing a probe array chip design database
Markowitz et al. Applying data warehouse concepts to gene expression data management
WO2000016220A1 (en) Method and apparatus for providing an expression data mining database and laboratory information management
EP1396800A2 (en) Method and apparatus for providing a bioinformatics database
JP2003526133A6 (en) Method and apparatus for providing expression data mining database and laboratory information management
JP2003526133A (en) Method and apparatus for providing expression data mining database and laboratory information management
EP1038245A1 (en) Method and apparatus for providing an expression data mining database and laboratory information management

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 1998937126

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1998937126

Country of ref document: EP